Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7619521002226382,-2.039233240340282,0.0,0.012206024394078932,0.012,11/19,10.48%,GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRM1;GRIK1;GRM8;GRIA2;GRIA1
prerank,solute:sodium symporter activity (GO:0015370),0.8608995940450412,2.012794407120767,0.0,0.005145120141757667,0.005,3/27,0.65%,SLC4A10;SLC4A4;SLC5A6
prerank,sulfate transmembrane transporter activity (GO:0015116),0.8924645126553824,1.8802686472270735,0.0,0.09621374665086836,0.158,3/14,3.93%,SLC26A7;SLC26A2;SLC26A6
prerank,anion:anion antiporter activity (GO:0015301),0.8512984673512932,1.8700734575961238,0.0,0.08129289823977115,0.186,4/17,6.24%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.8172915179832452,-1.866791944948837,0.0,0.11360991936027313,0.197,6/11,10.24%,KCNK2;KCNT2;KCND2;KCND3;KCNQ1;KCNT1
prerank,wide pore channel activity (GO:0022829),-0.6539264544719343,-1.8458812333673555,0.0,0.1048466197952934,0.266,5/23,4.86%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,cell adhesion mediator activity (GO:0098631),-0.6546775046718188,-1.8443585105030151,0.0029850746268656717,0.0798086210382084,0.27,14/24,13.16%,BSG;LRRC4C;ESAM;CNTN4;CD47;SIRPA;JAM3;ROBO4;CNTN2;DSCAML1;NINJ1;PALLD;BCAM;NEXN
prerank,gap junction channel activity (GO:0005243),-0.6629578004892555,-1.8360151773027176,0.0,0.07267279139243919,0.299,5/22,4.86%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,metalloendopeptidase activity (GO:0004222),0.6609395765836948,1.8303976461078568,0.003658536585365854,0.1515237881747633,0.392,15/76,8.22%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;ADAM9;ADAMTSL5;PHEX;MMP16;ADAMTS5;IDE;MMP14;NLN
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.8501374116810748,1.8224734718695315,0.0032258064516129032,0.13953565824446792,0.434,3/15,3.93%,SLC26A7;SLC26A2;SLC26A6
prerank,symporter activity (GO:0015293),0.9032577063274343,1.8188516729637423,0.001736111111111111,0.12485491543998606,0.455,2/10,0.65%,SLC4A4;SLC5A6
prerank,chloride transmembrane transporter activity (GO:0015108),0.8430451492725308,1.810746006178735,0.0015455950540958269,0.12451190743053554,0.499,3/16,3.93%,SLC26A7;SLC26A2;SLC26A6
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7246314347546715,-1.8100739074046528,0.0025906735751295338,0.08669407069640678,0.38,4/14,4.89%,SLC7A11;SLC1A3;SLC1A1;SLC1A2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8935204872241727,1.797004578058667,0.0033783783783783786,0.13930412783808885,0.585,2/11,0.16%,SLC23A1;SLC23A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7663057937805411,1.7733378385015743,0.0014925373134328358,0.18122256499302006,0.716,8/27,8.43%,SLC9A2;SLC23A1;SLC9B2;CNNM4;SLC9A8;SLC9C1;SLC9A1;SLC4A8
prerank,organic anion transmembrane transporter activity (GO:0008514),0.6116736105297783,1.7726283876687805,0.0,0.16546706375892656,0.721,17/134,5.36%,SLC26A7;SLC38A2;SLC26A2;SLC23A1;SLC23A2;SLC38A1;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1;SLC16A1;SLC6A7;ABCG2;SLC38A6;SLC26A6;SLC7A2;SFXN3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6678482111842077,-1.7258818796785227,0.007832898172323759,0.1979790330292363,0.722,8/15,16.73%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3;ALDH3B1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.7240723136793892,1.7216085743873124,0.005917159763313609,0.3064620651708749,0.918,2/29,0.13%,SLC26A7;SLC26A2
prerank,cation:chloride symporter activity (GO:0015377),0.8477211546883463,1.7164067265441836,0.013422818791946308,0.3012467842999114,0.934,3/10,2.58%,SLC12A7;SLC12A2;SLC12A8
prerank,retinoid binding (GO:0005501),-0.6189622491557836,-1.7158679920945021,0.014619883040935672,0.1952963903052629,0.764,6/22,2.22%,ALDH1A2;PTGDS;NR2F2;CYP26B1;ABCA4;RBP4
prerank,metal ion:proton antiporter activity (GO:0051139),0.8323400956047706,1.7093809192613265,0.006756756756756757,0.30229559725188504,0.952,5/13,8.27%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6934040958027035,-1.7081295060728727,0.018421052631578946,0.18684606572474674,0.79,7/13,13.44%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7141461560605405,1.7032579689458807,0.010189228529839884,0.30098952829282355,0.96,4/31,2.58%,KCNK5;SLC12A7;SLC12A2;SLC12A8
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.8351040168843363,1.6997191634836648,0.00676818950930626,0.292585832061286,0.969,5/12,8.27%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,cAMP binding (GO:0030552),-0.750578930666653,-1.6904303225720545,0.0,0.19980323008153822,0.848,7/11,8.42%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,sodium:proton antiporter activity (GO:0015385),0.8404646273877133,1.6811337715130652,0.008488964346349746,0.3378414513081628,0.983,5/11,8.27%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,nucleotidase activity (GO:0008252),0.7843957514858464,1.6756669707284289,0.014516129032258065,0.33764094294969726,0.986,4/15,6.55%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.7102707585172692,1.6692754461508736,0.020378457059679767,0.3407784573890828,0.989,4/27,3.93%,SLC26A7;SLC26A2;SLC39A14;SLC26A6
prerank,5'-nucleotidase activity (GO:0008253),0.7960360610447528,1.6685217440174798,0.018151815181518153,0.3253340704372453,0.99,4/13,6.55%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.7218582762193259,1.6666196090967265,0.016516516516516516,0.31642488871809654,0.991,9/27,8.43%,SLC23A1;SLC9B2;SLC12A2;CNNM2;CNNM4;ATP2B4;ITPR2;CLDN16;SLC4A8
prerank,adenylate cyclase binding (GO:0008179),-0.7411724128363615,-1.6665220902472306,0.012135922330097087,0.2275612659763247,0.909,6/10,14.04%,ADCY5;CAP2;CALM1;AKAP6;ADCY2;CALM3
prerank,metallopeptidase activity (GO:0008237),0.5775208526089883,1.6653012554605897,0.005827505827505828,0.30498312154571167,0.991,18/113,8.22%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;BMP1;ADAM9;ADAMTSL5;ADAM12;PHEX;MMP16;ADAMTS5;MYSM1;IDE;MMP14;NLN
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8163294836307795,1.6560544613901143,0.015544041450777202,0.32231838997138257,0.998,2/11,0.88%,EGFR;MAP3K5
prerank,solute:anion antiporter activity (GO:0140323),0.7795605226951826,1.649695770011516,0.0165016501650165,0.32960087029851076,0.999,4/14,6.24%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.779258243698864,1.6491931004043627,0.02866779089376054,0.31728240874172287,0.999,3/13,3.16%,BMP4;BMP5;BMP6
prerank,ligand-gated ion channel activity (GO:0015276),-0.5511159452802254,-1.6394622666217549,0.011695906432748537,0.26462034936394196,0.951,11/30,10.48%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4933071569496885,-1.6386563489170096,0.004273504273504274,0.24570943780270135,0.951,29/57,28.18%,COX4I1;UQCRH;UQCR10;COX5B;NDUFB9;CYB5A;COX6B1;NDUFA8;NDUFC1;COX8A;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFA4L2;NDUFS4;COX6A1;UQCR11;NDUFA13;COX10;COX4I2;NDUFB7;NDUFA6;NDUFA2;UQCRC1;NDUFA10;NDUFS6;NDUFV3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6422112015583177,1.6349139727492266,0.016150740242261104,0.3493330771447785,1.0,9/48,6.77%,PIEZO2;SLC12A7;SLC12A2;TRPM6;NALCN;TRPM4;CALHM5;TRPM7;CALHM2
prerank,ligand-gated channel activity (GO:0022834),-0.5552788386899653,-1.6303457400957102,0.005952380952380952,0.2459312717202607,0.956,11/29,10.48%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5669650740977661,-1.623172578990507,0.01592356687898089,0.24643650276660903,0.972,15/29,14.92%,GRIA4;GRID2;GABRG3;GRIK2;GABRA2;GABRB1;GRIK1;GABRB2;GABRB3;GABRA1;GRIA2;GLRA3;GABRG1;GABRA4;GABRA5
prerank,BMP receptor binding (GO:0070700),0.7792602180911148,1.6190438318419489,0.034482758620689655,0.38873361563341385,1.0,3/12,3.16%,BMP4;BMP5;BMP6
prerank,chemoattractant activity (GO:0042056),0.6799025147071457,1.6091108938544858,0.016819571865443424,0.40817953124610823,1.0,7/26,11.16%,BMP4;PGF;FGF2;DEFB130A;GDNF;VEGFA;CCL3
prerank,gated channel activity (GO:0022836),0.7670604744512967,1.6078644517946417,0.025559105431309903,0.3981220463975772,1.0,3/14,5.09%,PIEZO2;TMC6;TMC1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.6149169523829927,1.6024176957824763,0.008097165991902834,0.4020290428007887,1.0,5/53,3.57%,SLC47A1;SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6119112324817171,1.5838316089742497,0.017105263157894738,0.4554117341474436,1.0,7/55,3.57%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6
prerank,anion channel activity (GO:0005253),0.5955965561429555,1.5830565864624233,0.016209476309226933,0.44380810513096786,1.0,7/61,4.01%,SLC26A7;CLIC4;LRRC8D;ANO6;GLRB;ANO9;GABRA3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6240396306655025,-1.5826075200704741,0.023622047244094488,0.3350201599317146,0.994,4/15,4.89%,SLC1A3;SLC1A1;SLC1A5;SLC1A2
prerank,mechanosensitive ion channel activity (GO:0008381),0.7725258477596111,1.5803422781643548,0.03099510603588907,0.4396183591123066,1.0,3/12,5.09%,PIEZO2;TMC6;TMC1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6460174340073996,-1.57734245887134,0.026525198938992044,0.32774003961296105,0.994,10/15,21.08%,COX4I1;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;COX6A1;COX10;COX4I2
prerank,endopeptidase activity (GO:0004175),0.5172997330325653,1.575713571504792,0.0010515247108307045,0.44279215765429614,1.0,49/257,14.45%,ADAMTSL3;F3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;HTRA3;PCSK5;ADAMTS2;MMP28;ADAM9;USP46;USP2;USP13;ADAMTSL5;USP24;PRSS12;DDI2;CASP6;PHEX;HTRA4;MMP16;ADAMTS5;TASP1;IDE;PSMB2;PGC;ASPRV1;MMP14;NLN;USP34;USP49;BACE2;USP15;USP25;USP1;USP10;USP7;USP47;ADAMTS3;USP33;PMPCB;OMA1;MMP13;CLPP;PITRM1;PREP;ECE1;PCSK7
prerank,potassium ion antiporter activity (GO:0022821),0.745370675000359,1.5715147651211943,0.03820598006644518,0.44387254117069386,1.0,5/15,8.27%,SLC9A2;SLC24A3;SLC9A8;SLC9C1;SLC9A1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6938286604901545,-1.5672681622326134,0.026373626373626374,0.3341529584122634,0.995,4/10,6.67%,PRKAR2B;PRKAG2;PRKAR1B;PRKAR1A
prerank,leucine zipper domain binding (GO:0043522),0.7833974062097964,1.5633459657678488,0.05732484076433121,0.45994433998661105,1.0,5/10,12.04%,PAWR;ERC1;MRTFA;DDIT3;AATF
prerank,potassium:proton antiporter activity (GO:0015386),0.7965798910147704,1.5631793214653622,0.04203152364273205,0.44771120433527967,1.0,4/10,8.27%,SLC9A2;SLC9A8;SLC9C1;SLC9A1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.7318307932679382,1.562385262126187,0.04865771812080537,0.4387257850606875,1.0,5/14,11.77%,CAPN5;CAPN2;CAPN6;CAPN10;CAPN12
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6525366282030752,-1.5532282465722547,0.03233830845771144,0.35224510882993776,0.997,8/12,12.17%,PDE8B;PDE4B;PDE7B;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.592262711276622,-1.5526563169137868,0.03937007874015748,0.3359942945708574,0.997,7/18,16.73%,ALDH1A2;ALDH1A1;FAR2;ALDH9A1;HSD17B12;ALDH1A3;ALDH3B1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7114020506128467,1.549812865629513,0.03582554517133956,0.4717533578397911,1.0,6/18,6.69%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5959873598212454,1.5422001794715032,0.034210526315789476,0.4887864134669783,1.0,5/51,1.51%,SLC4A4;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1
prerank,chloride channel activity (GO:0005254),0.5781730559924965,1.5401110456483516,0.034394904458598725,0.4839500005337262,1.0,7/59,5.98%,SLC26A7;CLIC4;ANO6;GLRB;ANO9;GABRA3;CLIC1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.7511508222761684,1.53458842122808,0.058419243986254296,0.4915723077876374,1.0,2/12,4.28%,AOX1;FDX1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.7243493547119567,1.5306866210278645,0.06467661691542288,0.493809030748218,1.0,8/14,17.29%,USP13;MINDY3;USP15;USP7;OTUD7B;DESI2;OTUD5;USP9X
prerank,insulin-like growth factor I binding (GO:0031994),-0.6304037693510778,-1.529162998611033,0.03773584905660377,0.38187419175761234,0.998,6/13,3.80%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6597381582956418,-1.5287302231148217,0.05200945626477541,0.36566859093870036,0.998,2/11,4.62%,ITPR1;RYR2
prerank,R-SMAD binding (GO:0070412),0.6979163671131766,1.528644577013135,0.04807692307692308,0.4898393682866869,1.0,9/18,13.71%,DDX5;SMAD6;PMEPA1;LDLRAD4;SMAD2;JUN;SMURF1;PPM1A;PAX6
prerank,I-SMAD binding (GO:0070411),0.7426703669709822,1.527447638295291,0.07345575959933222,0.4830332336721039,1.0,6/13,12.98%,SMAD9;SMAD6;TGFBR1;TGFB1I1;SMAD2;SMURF1
prerank,histone deacetylase activity (GO:0004407),0.6861423170368262,1.5273557035473557,0.060221870047543584,0.4725049666183941,1.0,7/19,18.39%,HDAC4;HDAC9;HDAC8;MIER1;HDAC10;SIRT6;MIER2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6053522100505391,1.526441397635301,0.024691358024691357,0.4653425616906217,1.0,3/47,0.30%,SLC47A1;SLC38A2;SLC38A1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6761345584045836,-1.5251733345864582,0.05502392344497608,0.3585876865471216,0.999,3/10,2.82%,SLC6A13;SLC6A12;SLC6A1
prerank,retinoic acid binding (GO:0001972),-0.6413353498471659,-1.5185830176117472,0.06356968215158924,0.360468938355908,0.999,2/12,2.00%,NR2F2;CYP26B1
prerank,GABA-A receptor activity (GO:0004890),-0.5833696064121382,-1.515436227641668,0.03591160220994475,0.3525850984972708,0.999,9/18,14.92%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6204891616552386,1.492534761432784,0.0527086383601757,0.5748741257963024,1.0,6/32,7.17%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SFXN3;SLC6A19
prerank,delayed rectifier potassium channel activity (GO:0005251),0.611402828165736,1.492534428800111,0.061764705882352944,0.5628975815088795,1.0,4/32,3.03%,KCNB2;KCNQ5;KCNS3;KCNB1
prerank,calcium-activated potassium channel activity (GO:0015269),0.753630888577842,1.4906276822110498,0.07614213197969544,0.5579620287606508,1.0,2/11,0.91%,KCNMB2;KCNMB3
prerank,MHC class I protein binding (GO:0042288),-0.6128799341924799,-1.4894802690483813,0.0625,0.40352105496875146,1.0,6/13,21.72%,ATP5F1B;TAP2;ATP5F1A;ABCB9;TUBB4B;TAPBP
prerank,ATPase binding (GO:0051117),0.5426519470331659,1.4864995596943404,0.038366336633663366,0.5616413146742669,1.0,12/71,7.72%,EGFR;SLC2A13;PTPN3;ANK2;ATP1B1;PPP3CA;EZR;ATP6V0A4;SNTA1;ESR1;TOR1AIP1;RDX
prerank,histone acetyltransferase activity (GO:0004402),0.6179275276445161,1.4860579547531583,0.06880733944954129,0.5521823643901258,1.0,22/30,28.54%,KAT6B;NAA40;CREBBP;TADA3;SRCAP;BRCA2;BAZ1A;KAT2A;EP300;ATF2;KAT2B;EPC1;USP22;NAA50;KAT5;TAF1;HAT1;TADA2A;KAT14;TAF9;KAT6A;NAA60
prerank,receptor antagonist activity (GO:0048019),0.6741233351692427,1.4821503829345923,0.06946688206785137,0.5562072762476259,1.0,6/17,10.39%,ADH7;ESR2;LRPAP1;IGSF1;DKK3;IL18BP
prerank,calcium activated cation channel activity (GO:0005227),0.7036885537663458,1.4793462361734986,0.07293354943273905,0.5551293399740952,1.0,4/17,4.92%,KCNMB2;KCNMB3;ANO6;TRPM4
prerank,cation transmembrane transporter activity (GO:0008324),0.5783531995246057,1.4779856467069996,0.04871447902571042,0.5494416631381437,1.0,6/48,5.36%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SLC7A2;SFXN3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6527763571078136,-1.4768320721279793,0.08372093023255814,0.4218555040586083,1.0,6/11,13.27%,ITPR1;TRPC3;TRPC4;RPH3A;TRPC6;TRPC1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.5899584914925561,-1.4731902240896315,0.053475935828877004,0.41557489097752803,1.0,9/16,27.09%,SLC44A1;SLC22A4;SLC22A2;SLC44A2;SLC22A3;SLC5A7;SLC29A4;SLC25A42;SLC7A8
prerank,insulin-like growth factor binding (GO:0005520),-0.5738108863370711,-1.4647301563804784,0.06746987951807229,0.42332564708907705,1.0,6/15,3.80%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,SUMO transferase activity (GO:0019789),0.6826106510816811,1.461395019496055,0.07592891760904685,0.5988919845005924,1.0,5/16,9.75%,HDAC4;PIAS2;PIAS3;EGR2;RANBP2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6226195745314957,-1.457710806676131,0.07352941176470588,0.42774291126635067,1.0,9/12,14.92%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,mRNA methyltransferase activity (GO:0008174),0.7019585778050413,1.4480941234805458,0.10535117056856187,0.639593559907711,1.0,1/12,0.76%,RNMT
prerank,cation channel activity (GO:0005261),0.5144209831204931,1.4410220301176304,0.038461538461538464,0.6560118446006671,1.0,13/94,6.77%,PIEZO2;KCNK5;SLC24A3;PKD1;ANXA2;ANO6;TRPM6;NALCN;PKD2L2;TRPM4;CALHM5;TRPM7;CALHM2
prerank,phospholipase inhibitor activity (GO:0004859),0.7341812142331862,1.4362900728418666,0.1097770154373928,0.6633479206213013,1.0,3/10,2.55%,ANXA1;ANXA2;ANXA4
prerank,GTPase regulator activity (GO:0030695),-0.3382953046870518,-1.4336058356417154,0.0,0.47888201413097276,1.0,56/212,10.98%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;CHN2;ERRFI1;ARHGAP24;RASGRP3;ARHGAP32;ALDH1A1;RGS3;RAPGEF2;CPEB2;RGS5;RGS7;RIMS1;RALGAPA2;USP6NL;ARHGAP26;RABGAP1L;ARAP3;RGS12;RALGAPA1;CHN1;IQGAP2;TNK2;SIRPA;ARHGAP25;CCDC88A;TBC1D12;TBC1D8;OPHN1;ADGRB3;TBC1D9;VAV3;RHOH;ARL2BP;GMIP;ARHGAP39;ABR;ARHGAP15;ACAP2;GARNL3;HACD3;TBC1D30;SYDE2;TBC1D1;SMAP2;TBC1D16;SIPA1;RP2;RGS20;ELMOD1
prerank,phosphatase binding (GO:0019902),0.5030425330271273,1.428174871269425,0.03937947494033413,0.6834463656776811,1.0,25/105,11.24%,EGFR;MET;MAP3K5;WNK1;PPP1R3C;CRY2;SHOC2;ANAPC5;SFI1;AP3B1;VCP;STAT3;DLG1;IKBKE;VRK3;FCRL6;JUP;CNST;STYXL1;CDKN1B;IQGAP1;SMAD2;PPP6R3;MAST2;ERBB2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.45896904511389114,1.4265274984166982,0.0,0.6783669402902759,1.0,136/597,15.80%,BNC2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;PRRX2;RARB;NFIB;SOX9;ZIC4;HDAC4;HOXA5;PBX1;KLF3;CUX1;GLI3;NFAT5;SMAD6;FOXO3;HES1;MEOX2;GRHL1;HOXB6;KLF4;ZIC1;NFE2L2;ELF1;CRY2;ABL1;NR2F1;FOXC2;GLIS1;HOXA6;JDP2;NR4A2;FOXK1;KLF10;ARID4A;ZBTB7B;BHLHE40;NFATC4;ARID4B;GLIS2;ISL1;STAT3;ESR1;TBL1X;HOXB5;E2F3;GATA4;DDIT3;IRF1;NFIX;HOXC4;MBNL2;TEAD1;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;MCM7;GABPB2;GABPB1;SIX4;GLI2;PITX2;RXRA;FOXC1;NFKB1;EGR2;NFYA;PER3;MCM2;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;ATF7;LBX1;NFKB2;JUN;ELF3;ZBTB32;NCOR1;DDX11;FOXK2;ATF6;PER1;ZBED4;CREB3L1;ATOH7;BCL11B;NKX2-1;NR6A1;KMT2D;CDC45;NR4A1;NFATC3;CREB3L3;HNF4A;HNF1A;XRCC5;SP3;PAX6;RFX2;CHD3;E2F2;MLH3;BCL6;REST;ETV3;DHX9;ATF2;MCM9;FOXD2;RUNX2;NFATC1;RFX7;HSF2;HINFP;CALCOCO1;HOXD3;PRDM5;ZBTB7A
prerank,mannose binding (GO:0005537),0.6932924909611384,1.425869604928456,0.10701754385964912,0.669962119442314,1.0,2/12,5.65%,COLEC11;LMAN2L
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.7008644152639033,1.4258690403889833,0.11295681063122924,0.6591562788061476,1.0,6/11,21.77%,UBE4B;UBR5;UBE4A;UBE2K;ANAPC11;PPIL2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6367289061183226,-1.4258201799672372,0.0825242718446602,0.48398647206810574,1.0,6/11,32.48%,PPP1R1A;PPP1R14A;PABIR1;PPP1R2;PPP1R8;PPP1R11
prerank,sequence-specific DNA binding (GO:0043565),0.4578684474723409,1.420328245093862,0.0,0.6702049830368272,1.0,97/590,11.22%,FOXP2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;SLTM;PRRX2;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;CUX1;GLI3;NFAT5;FOXO3;HES1;MEOX2;GRHL1;HOXB6;KLF4;ZIC1;NFE2L2;ZNF148;ELF1;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;GLIS1;HOXA6;JDP2;SMG6;FOXL1;TELO2;NR4A2;FOXK1;KLF10;ZBTB7B;BHLHE40;NFATC4;GLIS2;ISL1;ESR1;MBD1;KDM1A;HOXB5;E2F3;GATA4;RORA;NFIX;HOXC4;MBNL2;TEAD1;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;SOX14;SP8;SIX4;GLI2;PITX2;STN1;RXRA;FOXC1;GRHL2;EGR2;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;ATF7;LBX1;NFKB2;JUN;ELF3;ZBTB32;FOXK2;ATF6;CBFB
prerank,double-stranded DNA binding (GO:0003690),0.4578453664804773,1.4153966918138103,0.007042253521126761,0.6788825242044813,1.0,116/531,16.50%,EGFR;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;PRRX2;RARB;NFIB;SOX9;ZIC4;HOXA5;PBX1;KLF3;CUX1;GLI3;NFAT5;FOXO3;HES1;MEOX2;GRHL1;HOXB6;KLF4;ZIC1;ELF1;ABL1;NR2F1;FOXC2;GLIS1;HOXA6;JDP2;NR4A2;FOXK1;HDGFL3;KLF10;ZBTB7B;BHLHE40;NFATC4;GLIS2;ISL1;ESR1;MBD1;HOXB5;E2F3;GATA4;NFIX;HOXC4;MBNL2;TEAD1;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;SIX4;GLI2;CAMTA2;PITX2;ERCC5;RXRA;EGR2;RARG;GATA1;HOXB4;FOXE1;RARA;TOP1;ATF7;SMAD2;LBX1;NFKB2;APEX1;JUN;ELF3;ZBTB32;DDX11;ATF6;CREB3L1;ATOH7;BCL11B;NR6A1;NR4A1;PRKDC;NFATC3;HNF4A;XRCC5;SP3;PAX6;RFX2;E2F2;BCL6;ETV3;POLG2;DHX9;ATF2;FOXD2;RUNX2;NFATC1;RFX7;HSF2;KIN;HOXD3;ZBTB7A;RBBP8;TFAP2A;POU6F1;YY1;XPA;ZFP1
prerank,androgen receptor binding (GO:0050681),0.6096139974062181,1.4131624793494613,0.10790273556231003,0.6774144334332634,1.0,9/25,16.54%,FOXP1;DDX5;KDM1A;TGFB1I1;SMARCA4;EP300;ZBTB7A;NSD1;RNF14
prerank,thiol-dependent deubiquitinase (GO:0004843),0.513666408857626,1.4126376501962097,0.06265664160401002,0.6688656184284967,1.0,37/83,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP32;USP10;USP7;USP47;OTUD7B;DESI2;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;OTUD3;BAP1;VCPIP1;OTUD5;USP28;USP9X;USP22;USP40;PSMD14;UFD1;USP21;USP36
prerank,cholesterol binding (GO:0015485),-0.4312874653153038,-1.4121289203050869,0.024691358024691357,0.5099785110477175,1.0,14/47,10.21%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;CD81;ABCG1;OSBPL1A;NPC2;SYP
prerank,Notch binding (GO:0005112),0.6282222434652072,1.4116028209069935,0.11145038167938931,0.6625839642852761,1.0,8/22,14.03%,CCN3;SNED1;TCIM;JAG1;AAK1;GALNT11;NCOR2;CUL3
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5935917390722998,-1.4107971016411203,0.09950248756218906,0.49807207233395395,1.0,9/12,36.89%,SLC2A1;SLC5A3;MFSD4A;SLC2A4;SLC2A8;PPBP;SLC2A5;SLC2A6;SLC2A3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6863403567171682,1.4090514858999157,0.11705685618729098,0.6622374930694089,1.0,5/12,9.50%,DDI2;SPPL2A;PGC;ASPRV1;BACE2
prerank,cytokine activity (GO:0005125),0.4857625725018694,1.401886429412824,0.03542857142857143,0.6795137801131779,1.0,26/131,11.58%,BMP4;TNFRSF11B;WNT9A;BMP5;TGFB3;WNT11;BMP6;INHBA;FGF2;FAM3C;CLCF1;WNT16;SLURP1;GDF6;IL10;GDF5;CXCL2;IL33;GDF10;CTF1;TIMP1;VEGFA;INHBB;TNFSF11;CCL3;CCL1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6005506718314886,-1.3973797558258287,0.09777777777777778,0.5205936470142764,1.0,4/11,10.53%,KCNJ3;KCND3;KCNQ1;KCNJ8
prerank,manganese ion binding (GO:0030145),0.5480679824117307,1.397273473034416,0.07275132275132275,0.6873145492225134,1.0,11/48,14.56%,ME1;MPPED2;LARGE1;ABL1;XPNPEP1;B4GALT1;XPNPEP3;WRN;LARGE2;DYRK2;MGAT1
prerank,cyclic nucleotide binding (GO:0030551),-0.5171745498829499,-1.396793783751146,0.07103825136612021,0.5079323185356563,1.0,7/21,8.42%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.46858362857277086,1.3966783759725052,0.031487513572204126,0.6798225503360145,1.0,55/188,16.31%,BNC2;VSX1;SIX1;TCF7L2;HDAC4;PBX1;SMAD6;FOXO3;GRHL1;KLF4;NFE2L2;CRY2;FOXC2;FOXK1;ARID4A;ARID4B;GLIS2;STAT3;TBL1X;GATA4;DDIT3;IRF1;GABPB2;GABPB1;PITX2;RXRA;FOXC1;NFKB1;EGR2;NFYA;PER3;GATA1;CTCFL;JUN;NCOR1;FOXK2;ATF6;PER1;ZBED4;CREB3L1;NKX2-1;KMT2D;CREB3L3;HNF4A;HNF1A;XRCC5;PAX6;CHD3;REST;DHX9;HINFP;CALCOCO1;PRDM5;TFAP2A;YY1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7205938526922956,1.3934215307755717,0.12121212121212122,0.6816140827797408,1.0,5/10,18.72%,DSE;GLCE;RENBP;GALE;GNE
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4476699130429505,1.3922613455272685,0.001001001001001001,0.6762802299204544,1.0,175/732,16.38%,FOXP2;ZBTB7C;FOXP1;KLF12;PBX3;NR3C2;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;FOXN3;FOXP4;PBX1;KLF3;NFIA;GLI3;NFAT5;FOXO3;HES1;MEOX2;HOXA3;ZBTB16;GRHL1;SKIL;HOXB6;ESR2;KLF4;ZIC1;NFE2L2;ZNF148;PRRX1;ELF1;ZNF423;NR2F1;FOXC2;MEF2A;GLIS1;KLF7;HOXA6;JDP2;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;BHLHE40;FOXO6;NFATC4;KLF9;GLIS2;ISL1;SKI;STAT3;HOXB3;ESR1;ATF1;HOXB5;E2F3;E2F5;GATA4;NFIL3;RORA;DDIT3;HIF3A;IRF1;NFIX;REL;HOXC4;TEAD1;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;MLXIP;SIX4;GLI2;PITX2;HIVEP3;ZNF8;RXRA;FOXC1;GRHL2;ATOH8;NFKB1;EGR2;NFYA;RBMX;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;TOP1;ATF7;CARF;SMAD2;NFE2L1;NRF1;NFKB2;JUN;PRDM15;ZBTB32;MYNN;MXD1;FOXK2;GTF2IRD1;ATF6;PER1;BPTF;ATOH7;BCL11B;MTA1;NKX2-1;NR6A1;TCF3;NR4A1;CC2D1B;MXD4;NFATC3;CREB3L3;HNF4A;HNF1A;SP3;PAX6;RFX2;STAT5A;E2F2;BCL6;EBF4;DNMT3A;REST;DHX9;ZNF691;ATF2;FOXD2;RUNX2;NFATC1;RFX7;HSF2;THRAP3;ZNF585B;ZNF585A;HINFP;CALCOCO1;ZBTB1;HOXD3;PRDM5;ZBTB7A;ZKSCAN1;TFAP2A;POU6F1;NSD1;YY1;ZNF219
prerank,cholesterol transfer activity (GO:0120020),-0.5478943886295213,-1.3871168866764654,0.10621761658031088,0.5211794781821063,1.0,5/16,9.77%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4450693124103533,1.3852336210199003,0.001,0.6916571100834719,1.0,175/731,16.38%,FOXP2;ZBTB7C;FOXP1;KLF12;PBX3;NR3C2;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;FOXP4;PBX1;KLF3;NFIA;GLI3;NFAT5;FOXO3;HES1;MEOX2;HOXA3;ZBTB16;GRHL1;SKIL;HOXB6;ESR2;KLF4;ZIC1;NFE2L2;ZNF148;PRRX1;ELF1;ZNF423;NR2F1;FOXC2;MEF2A;GLIS1;KLF7;HOXA6;JDP2;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;BHLHE40;FOXO6;NFATC4;KLF9;GLIS2;SKI;STAT3;HOXB3;ESR1;ATF1;HOXB5;E2F3;E2F5;GATA4;NFIL3;RORA;DDIT3;HIF3A;IRF1;NFIX;REL;HOXC4;TEAD1;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;MLXIP;SIX4;GLI2;PITX2;HIVEP3;ZNF8;RXRA;FOXC1;GRHL2;ATOH8;NFKB1;EGR2;NFYA;RBMX;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;TOP1;ATF7;CARF;SMAD2;NFE2L1;NRF1;NFKB2;JUN;PRDM15;ZBTB32;MYNN;MXD1;FOXK2;GTF2IRD1;ATF6;PER1;BPTF;CREB3L1;ATOH7;BCL11B;MTA1;NKX2-1;NR6A1;TCF3;NR4A1;CC2D1B;MXD4;NFATC3;CREB3L3;HNF4A;HNF1A;SP3;PAX6;RFX2;STAT5A;E2F2;BCL6;EBF4;DNMT3A;REST;DHX9;ZNF691;ATF2;FOXD2;RUNX2;NFATC1;RFX7;TWIST1;HSF2;THRAP3;ZNF585B;ZNF585A;HINFP;CALCOCO1;ZBTB1;HOXD3;PRDM5;ZBTB7A;ZKSCAN1;TFAP2A;POU6F1;NSD1;YY1;ZNF219
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5427214289380329,-1.3825951731131543,0.10298102981029811,0.5211280576832363,1.0,4/17,11.64%,SLC2A1;SLC5A3;SLC5A11;MFSD4A
prerank,calcium channel regulator activity (GO:0005246),-0.44976031230810937,-1.3821408622779954,0.08487084870848709,0.5089213997365573,1.0,9/37,9.70%,ITPR1;PRKG1;NRXN1;CALM1;SGK1;REM1;CACNG4;CACNG7;SLC30A1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5677243017413025,1.3817223336815332,0.11715481171548117,0.6957437260490388,1.0,14/33,17.03%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;ERBB2;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,deubiquitinase activity (GO:0101005),0.497549233878041,1.3801049287270775,0.0754017305315204,0.6927633475079764,1.0,37/88,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP32;USP10;USP7;USP47;OTUD7B;DESI2;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;OTUD3;BAP1;VCPIP1;OTUD5;USP28;USP9X;USP22;USP40;PSMD14;UFD1;USP21;USP36
prerank,GABA receptor binding (GO:0050811),-0.5842544379489902,-1.378457620980949,0.12808988764044943,0.5060805498775803,1.0,6/11,25.09%,PLCL2;JAKMIP1;GABARAPL1;GABARAP;TRAK2;GABARAPL2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6901771389006961,1.3780499938225892,0.13356164383561644,0.6912635959806679,1.0,8/10,28.54%,NAA40;BRCA2;EP300;ATF2;USP22;NAA50;HAT1;NAA60
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7100156991945147,1.3772541721507237,0.12926391382405744,0.685171691493144,1.0,3/10,5.81%,EHHADH;AUH;ECHDC1
prerank,transcription corepressor binding (GO:0001222),0.5942838577845194,1.3769098890598346,0.10463378176382661,0.6779575016157039,1.0,13/27,19.11%,ZBTB16;ESR1;RORA;LCOR;EHMT1;PER3;PER1;EED;SUZ12;ZBTB7A;NEK6;EHMT2;PER2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5397799827157285,1.37567289282671,0.09342105263157895,0.6734061869535979,1.0,7/46,6.02%,EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;MGAT3
prerank,transforming growth factor beta binding (GO:0050431),0.5972649463341474,1.3730744461077242,0.13313609467455623,0.6743664505800548,1.0,10/23,9.60%,THBS1;CD109;TGFB3;TGFBR1;LTBP3;TGFBR2;TSKU;ITGAV;LTBP4;ACVR1
prerank,aspartic-type peptidase activity (GO:0070001),0.6913715338733474,1.3715017624421164,0.1456140350877193,0.6715260220139909,1.0,4/10,9.50%,DDI2;PGC;ASPRV1;BACE2
prerank,microtubule plus-end binding (GO:0051010),0.6168267588920375,1.3648583876934013,0.13153724247226625,0.6857019392779109,1.0,5/20,9.27%,CLIP4;MAPRE2;CLIP1;PAFAH1B1;FBXW11
prerank,sterol binding (GO:0032934),-0.4017546393027475,-1.3645801934872623,0.04954954954954955,0.5320040388346111,1.0,15/56,10.21%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;INSIG2;CD81;ABCG1;OSBPL1A;NPC2;SYP
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.519299596506569,-1.364387315181276,0.13471502590673576,0.5078055515361354,1.0,4/16,4.23%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.519299596506569,-1.364387315181276,0.13471502590673576,0.5078055515361354,1.0,4/16,4.23%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,histone methyltransferase activity (GO:0042054),0.5701385635026478,1.3616481600095764,0.10344827586206896,0.6889805881255588,1.0,13/32,21.67%,SMYD2;KMT2C;SETD2;EHMT1;PRMT8;EED;PRMT6;SUZ12;KMT5A;CARM1;EHMT2;KMT5B;PRMT5
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.678667525488761,1.3591334960762314,0.17986798679867988,0.6899303455971045,1.0,3/10,1.51%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5656921923459353,-1.3552709528448093,0.12944162436548223,0.5191614816145915,1.0,3/12,4.22%,CDK8;CDK19;CDK6
prerank,serine-type peptidase activity (GO:0008236),0.4857311401345988,1.3537896983393325,0.08262454434993925,0.7009687750339288,1.0,5/96,4.73%,F3;HTRA3;PCSK5;HTRA1;PRSS12
prerank,sterol transfer activity (GO:0120015),-0.5326593607599126,-1.3533671424514253,0.11684782608695653,0.5130703245305999,1.0,5/17,9.77%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.525694657268494,-1.3505424029925497,0.10242587601078167,0.5092647301542965,1.0,3/16,4.80%,SLC13A3;SLC1A1;SLC1A5
prerank,amino acid:sodium symporter activity (GO:0005283),0.6642809435267396,1.34659817714513,0.17993079584775087,0.7178447966055507,1.0,2/11,0.30%,SLC38A2;SLC38A1
prerank,GTPase inhibitor activity (GO:0005095),0.6450470724958268,1.3459057677032054,0.1617161716171617,0.7119910799803201,1.0,2/13,4.08%,SLIT2;PDE6D
prerank,potassium channel activity (GO:0005267),0.48861967010581475,1.3455587776469624,0.09878048780487805,0.7051820731818917,1.0,7/89,3.03%,KCNB2;KCNK5;KCNMB2;KCNMB3;KCNQ5;KCNS3;KCNB1
prerank,acetylation-dependent protein binding (GO:0140033),0.6140877492439564,1.3440806640473284,0.1450381679389313,0.6947834543953287,1.0,7/20,17.04%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.6140877492439564,1.3440806640473284,0.1450381679389313,0.6947834543953287,1.0,7/20,17.04%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,GTPase activator activity (GO:0005096),-0.3059837294809283,-1.3409286069071185,0.0,0.5233208101919667,1.0,79/313,11.62%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;RAPGEF5;DOCK10;CHN2;RAPGEF4;ERRFI1;DENND2A;ARHGAP24;RASGRP3;ELMO1;DOCK11;RAPGEF3;ARHGAP32;ALDH1A1;RGS3;FGD5;DOCK4;RAPGEF2;SBF2;RGS5;RALGPS1;RGS7;RALGAPA2;USP6NL;ARHGAP26;RASGRF2;RABGAP1L;ARAP3;RASGRP2;RALGAPA1;RASGRF1;CHN1;IQGAP2;ARHGEF15;EEF1B2;EPS8L2;ARHGAP25;RAB3IP;RGL1;CCDC88A;TBC1D12;TBC1D8;OPHN1;ADGRB3;CYTH1;TBC1D9;DENND5A;SPATA13;VAV3;GMIP;ARHGAP39;DENND5B;ABR;ARHGAP15;ACAP2;GARNL3;HACD3;TBC1D30;DENND1A;RAPGEF1;SYDE2;DOCK2;TBC1D1;SMAP2;TBC1D16;SIPA1;RP2;ARHGEF11;RGS20;ELMOD1;ARHGEF7;ARHGEF4;RGS16
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4365206944662385,-1.3406494390576547,0.08038585209003216,0.5026122760701576,1.0,16/34,28.18%,NDUFB9;NDUFA8;NDUFC1;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA6;NDUFA2;NDUFA10;NDUFS6;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4365206944662385,-1.3406494390576547,0.08038585209003216,0.5026122760701576,1.0,16/34,28.18%,NDUFB9;NDUFA8;NDUFC1;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA6;NDUFA2;NDUFA10;NDUFS6;NDUFV3
prerank,sodium channel activity (GO:0005272),-0.43358698368802395,-1.340295520382098,0.09771986970684039,0.4935552909993486,1.0,11/37,15.68%,SCN7A;SHROOM2;GRIK2;HCN1;GRIK1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,ligand-gated anion channel activity (GO:0099095),-0.5254732208310162,-1.336654189371654,0.12760416666666666,0.4930092417029257,1.0,11/17,14.92%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,omega peptidase activity (GO:0008242),0.48274595689471933,1.3363613329752837,0.08478802992518704,0.7131024666038263,1.0,37/89,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP32;USP10;USP7;USP47;OTUD7B;DESI2;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;OTUD3;BAP1;VCPIP1;OTUD5;USP28;USP9X;USP22;USP40;PSMD14;UFD1;USP21;USP36
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6692168517485919,1.3350783000602844,0.1524822695035461,0.7024731053118926,1.0,3/10,11.95%,DUSP5;DUSP16;DUSP10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6692168517485919,1.3350783000602844,0.1524822695035461,0.7024731053118926,1.0,3/10,11.95%,DUSP5;DUSP16;DUSP10
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5504538923659276,-1.334983972225068,0.16842105263157894,0.487717344539151,1.0,6/14,5.91%,COL4A3;TIMP3;SPOCK2;SPOCK3;SPOCK1;BST2
prerank,monocarboxylic acid binding (GO:0033293),-0.5097275786592178,-1.332906877671547,0.1225071225071225,0.48333376421430413,1.0,5/18,18.57%,NR2F2;CYP26B1;NAPEPLD;PSAP;NR1H4
prerank,mRNA 5'-UTR binding (GO:0048027),-0.47490143769312465,-1.3322874362543533,0.12232415902140673,0.47603495136907836,1.0,11/24,24.41%,RPS14;RPS13;RPL41;RPS7;RPL26;MYH10;MRPS11;RPL5;DDX3X;IGF2BP1;SHMT2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.44173162479476824,1.3299602733493114,0.03995793901156677,0.7117380089991849,1.0,68/254,15.68%,KLF5;TFCP2L1;SIX1;PLAGL1;NFIB;SOX9;HOXA5;NFIA;NFAT5;FOXO3;MEOX2;ZBTB16;GRHL1;KLF4;PRRX1;ELF1;FOXC2;MEF2A;KLF7;EHF;NR4A3;NR4A2;KLF10;GLIS2;STAT3;HOXB3;ESR1;ATF1;E2F3;GATA4;DDIT3;PLSCR1;IRF1;REL;HOXC4;MYOG;MLXIP;MDM4;FOXC1;GRHL2;NFKB1;EGR2;GATA1;CTCFL;SMAD2;NRF1;NFKB2;JUN;ELF3;PRDM15;FOXK2;ATF6;CREB3L1;TCF3;NR4A1;NFATC3;CREB3L3;HNF4A;HNF1A;E2F2;ATF2;FOXD2;NFATC1;HSF2;ZNF585B;ZNF585A;HINFP;HOXD3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.49151539370073766,1.3249614574908612,0.10246913580246914,0.7222891159004139,1.0,16/70,16.37%,EXT1;MGAT4C;B3GNT2;GXYLT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;B3GALT6;B4GAT1;B4GALNT3;LARGE2;POMGNT2;B3GNT9
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5144232310090548,-1.3249094901302274,0.14447592067988668,0.47603495136907836,1.0,8/17,13.84%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,ephrin receptor activity (GO:0005003),-0.5144232310090548,-1.3249094901302274,0.14447592067988668,0.47603495136907836,1.0,8/17,13.84%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,DNA-binding transcription factor binding (GO:0140297),0.44190163410606914,1.322975521422137,0.059957173447537475,0.7214943628063519,1.0,56/189,16.12%,ZFPM2;TCF7L2;HDAC4;HES1;HDAC9;WWP2;KLF4;NFE2L2;GSK3B;PRRX1;MEF2A;TXLNG;BHLHE40;TLE2;CREBBP;TLE6;ISL1;SKI;STAT3;ZMYND8;KDM1A;GATA4;DDIT3;ID2;PITX2;PIAS2;PIAS3;EGR2;DACT1;CBX5;GATA1;SMAD2;MTDH;TCERG1;JUN;NCOR1;MIER1;RB1;MTA1;DDRGK1;TCF3;HIRA;HNF4A;HCFC1;CRTC1;EP300;TLE3;DHX9;ATF2;TLE4;NFATC1;TWIST1;PRDM5;ZBTB7A;RBBP8;NEK6
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5804998406722947,-1.3219777098096812,0.16326530612244897,0.4746842172256041,1.0,3/11,5.64%,SASH1;ROR2;DAB2IP
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42373728814874656,1.320907370104589,0.003,0.7206948286728148,1.0,135/831,11.23%,FOXP2;ZBTB7C;FOXP1;KLF12;PBX3;NR3C2;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;FOXP4;PBX1;KLF3;CUX1;NFIA;GLI3;NFAT5;FOXO3;HES1;MEOX2;HOXA3;ZBTB16;GRHL1;TWIST2;SKIL;PURG;HOXB6;ESR2;KLF4;ZIC1;NFE2L2;ZNF148;PRRX1;ELF1;ZNF423;NR2F1;FOXC2;MEF2A;GLIS1;KLF7;HOXA6;JDP2;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;BHLHE40;FOXO6;NFATC4;KLF9;GLIS2;SKI;STAT3;HOXB3;ESR1;ATF1;HOXB5;E2F3;E2F5;GATA4;NFIL3;RORA;DDIT3;HIF3A;IRF1;NFIX;REL;HOXC4;TEAD1;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;SOX14;SP8;MLXIP;SIX4;GLI2;PITX2;HIVEP3;ZNF8;RXRA;FOXC1;GRHL2;ATOH8;NFKB1;EGR2;NFYA;RBMX;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;TOP1;ATF7;ZNF25;CARF;SMAD2;NFE2L1;NRF1;NFKB2;JUN;PRDM15;ZBTB32;MYNN;MXD1;FOXK2;GTF2IRD1;ATF6;PER1
prerank,protein phosphatase binding (GO:0019903),0.45461317629828657,1.3141680543869423,0.08548009367681499,0.7373424901333442,1.0,24/117,11.24%,EGFR;MET;MAP3K5;PPP1R3B;PPP1R3C;STRN;SHOC2;ANAPC5;AP3B1;VCP;ATP2B4;STAT3;IKBKE;VRK3;FCRL6;JUP;STYXL1;SLC9A1;CDKN1B;STRN3;IQGAP1;BOD1L1;PPP6R3;ERBB2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4418466991521739,1.3102805515469091,0.06060606060606061,0.7429450582295236,1.0,57/181,18.78%,ZFPM2;TCF7L2;HDAC4;TACC2;HES1;ANXA4;WWP2;KLF4;NFE2L2;GSK3B;MDFIC;PRRX1;MEF2A;BCAS3;BHLHE40;CREBBP;ISL1;STAT3;KDM1A;TADA3;GATA4;ID2;JUP;PITX2;PIAS2;RXRA;PIAS3;EGR2;DACT1;GATA1;MTDH;TCERG1;JUN;NCOR1;MIER1;RB1;MTA1;DDRGK1;SMARCA4;TCF3;NCOR2;HIRA;HNF4A;EP300;DHX9;ATF2;BAZ2A;NFATC1;RBBP8;TAF4;NRIP1;CPNE1;BCL10;PPARG;HCLS1;MIER2;PIAS1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.4969949275359186,-1.3094973373635046,0.1509433962264151,0.4953476663586489,1.0,5/19,8.06%,ITPR1;GRIN2A;RYR2;GRIN2B;GRIN1
prerank,poly-purine tract binding (GO:0070717),-0.44081150200534097,-1.3087664622474948,0.10543130990415335,0.48873430921324396,1.0,5/27,6.69%,RBPMS;RBMS1;ATXN1;KHDRBS2;ELAVL4
prerank,proton transmembrane transporter activity (GO:0015078),-0.4197648288256983,-1.308489623855988,0.10452961672473868,0.48105819986971854,1.0,15/39,21.08%,COX4I1;SLC33A1;UQCRH;UQCR10;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;COX6A1;ATP6V1F;UQCR11;COX10;COX4I2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5185181543418925,1.3083487429277294,0.14325068870523416,0.7423746121369751,1.0,12/42,13.87%,PTPN3;NEDD4;VAV2;SHC1;IRS1;ABL1;NCK2;CBLC;BCAR3;PLCG2;YES1;PIK3R3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6235754006570139,1.306196322613157,0.1616871704745167,0.7422390670383074,1.0,1/14,0.28%,KCNJ2
prerank,RNA polymerase II complex binding (GO:0000993),0.5482203388363049,1.3048171764711765,0.16524216524216523,0.7399581911056764,1.0,13/32,17.03%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,FAD binding (GO:0071949),0.558685313915691,1.3047383771904661,0.17477203647416414,0.7330312032733014,1.0,4/24,6.96%,MICAL2;CRY2;MMACHC;AGPS
prerank,sodium channel regulator activity (GO:0017080),0.5247792552344981,1.3003702387708709,0.14522821576763487,0.7402798859960932,1.0,8/37,5.95%,PTPN3;NEDD4;FXYD5;CAMK2D;FGF13;SGK3;ATP2B4;SNTA1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6527912295019942,1.2988350705501022,0.19320214669051877,0.7388101290348439,1.0,5/10,20.21%,SMYD2;SETD2;SETD5;NSD1;ASH1L
prerank,glucuronosyltransferase activity (GO:0015020),0.5851663321980174,1.298018557568955,0.18125,0.7341846016113343,1.0,2/19,3.36%,EXT1;LARGE1
prerank,nuclear receptor binding (GO:0016922),0.45952236771844945,1.2973992953557634,0.11488862837045721,0.7293970040962494,1.0,36/111,16.96%,FOXP1;TCF7L2;DDX5;TACC2;JMJD1C;STRN;NR4A3;NR4A2;BCAS3;ISL1;ESR1;KDM1A;TADA3;TGFB1I1;TRIP12;LCOR;JUP;RXRA;MED13;NCOR1;DNAAF4;DCAF1;SMARCA4;NR4A1;NCOR2;TRIP6;EP300;MED14;BAZ2A;THRAP3;ZBTB7A;MED24;NSD1;RNF14;NRIP1;BRD8
prerank,death receptor binding (GO:0005123),0.6187443030688352,1.296681157333506,0.22837370242214533,0.7251598411905169,1.0,5/15,15.70%,NGF;EDA;FEM1B;MYD88;PIDD1
prerank,O-acyltransferase activity (GO:0008374),0.5467261731206892,1.2918639999653427,0.18786127167630057,0.7348073491180418,1.0,11/30,20.17%,SOAT1;MOGAT3;PLA2G15;MBOAT4;MBOAT1;DGAT2L6;LCAT;MOGAT1;GPAT3;PLA2G4A;LPCAT1
prerank,NAD binding (GO:0051287),0.5537657036380481,1.2877232758494128,0.1985185185185185,0.7416574803259404,1.0,2/26,1.81%,ME1;BDH2
prerank,lipid phosphatase activity (GO:0042577),0.6289110466170499,1.286603836950742,0.2030716723549488,0.7383063649131475,1.0,2/14,2.20%,PLPPR2;PLPP3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.47130062496057046,-1.2841502843987687,0.1501416430594901,0.5211790688861371,1.0,5/21,7.11%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.47130062496057046,-1.2841502843987687,0.1501416430594901,0.5211790688861371,1.0,5/21,7.11%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,protease binding (GO:0002020),0.4605120277885874,1.28352889197581,0.13089622641509435,0.7413435143723007,1.0,15/99,6.98%,F3;SLC2A13;FN1;ANXA2;COL3A1;ITGB1;CRADD;GSK3B;SERPINB9;VCP;LDLR;TIMP2;ITGAV;RIPK2;LCOR
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4835989535023278,1.27715606473242,0.16031537450722733,0.7547439921630273,1.0,8/53,7.75%,MICAL2;AOX1;CRY2;KDM1A;ACOX3;MMACHC;AGPS;GSR
prerank,protein kinase C binding (GO:0005080),0.5162648354132277,1.276910811359239,0.18169014084507043,0.7489236878342459,1.0,11/43,11.20%,GRK5;ADAM9;DSP;HDAC9;IRS1;ABL1;NELL1;ITGAV;PDLIM5;DACT1;PRKCSH
prerank,diacylglycerol kinase activity (GO:0004143),-0.5487438303073227,-1.276402127977771,0.19901719901719903,0.5312675843415527,1.0,4/11,8.68%,DGKB;DGKI;DGKD;DGKG
prerank,SUMO binding (GO:0032183),0.6165611057041055,1.2753241891024767,0.2193877551020408,0.7473996677646703,1.0,7/13,21.02%,HERC2;USP25;RNF111;SERBP1;PML;CASP8AP2;TDG
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.49396935979421674,-1.273171277991351,0.16709511568123395,0.530565952177722,1.0,10/17,13.71%,GRIA4;GRIK2;GRIN2A;GRIN2B;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1;GRIN3A
prerank,tau-protein kinase activity (GO:0050321),0.5700358744284496,1.270990186183726,0.22153846153846155,0.7551277352667176,1.0,5/20,10.12%,MARK1;GSK3B;MARK2;SIK3;MARK3
prerank,peptidoglycan binding (GO:0042834),-0.5554280011605806,-1.268891256454852,0.19230769230769232,0.53271712855531,1.0,2/10,5.32%,NOD1;PGLYRP1
prerank,inward rectifier potassium channel activity (GO:0005242),0.5528600502409142,1.2670301261495442,0.2050520059435364,0.7616260302045583,1.0,2/24,2.75%,KCNJ2;KCNJ15
prerank,transcription cis-regulatory region binding (GO:0000976),0.4112557332504928,1.2649563659020715,0.042726347914547304,0.7618755549742874,1.0,93/406,16.31%,BNC2;FOXP1;VSX1;SIX1;TCF7L2;PLAGL1;SOX9;HDAC4;FOXN3;PBX1;CUX1;GLI3;SMAD6;FOXO3;GRHL1;TWIST2;PURG;KLF4;NFE2L2;CRY2;FOXC2;MEF2A;FOXK1;KLF10;ARID4A;ZBTB7B;ARID4B;GLIS2;ISL1;STAT3;ATF1;TBL1X;E2F3;GATA4;NFIL3;RORA;DDIT3;HIF3A;IRF1;TEAD1;MYOG;DMBX1;BARHL2;LHX2;PHOX2A;MLXIP;GABPB2;GABPB1;PITX2;RXRA;FOXC1;GRHL2;NFKB1;EGR2;NFYA;PER3;GATA1;CTCFL;RARA;ZNF25;SMAD2;JUN;NCOR1;FOXK2;ATF6;PER1;ZBED4;CREB3L1;RB1;NKX2-1;TCF3;KMT2D;CREB3L3;HNF4A;HNF1A;XRCC5;SP3;PAX6;CHD3;PRDX5;E2F2;REST;ATF2;TWIST1;HSF2;HINFP;CALCOCO1;HOXD3;PRDM5;TFAP2A;AGO2;TAF4;YY1
prerank,phospholipid transfer activity (GO:0120014),0.5771699326423284,1.2642491772174551,0.1968,0.7576875424757065,1.0,3/21,2.62%,TNFAIP8L3;PITPNC1;PITPNA
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.427435926047741,1.2640548626057986,0.09646302250803858,0.7521825474017196,1.0,18/173,6.34%,FOXP2;FOXP1;KLF12;ZFHX3;PLAGL1;FOXP4;FOXO3;HES1;ZBTB16;SKIL;ZNF148;NR2F1;JDP2;FOXK1;BHLHE40;NFATC4;SKI;NFIL3
prerank,ion channel inhibitor activity (GO:0008200),0.5202915266931073,1.2588643340806431,0.1742857142857143,0.7630887940081278,1.0,8/35,10.46%,KCNMB2;NEDD4;CAMK2D;WNK1;STX8;TNNI3;COMMD1;MCUB
prerank,E-box binding (GO:0070888),-0.4079611673574392,-1.2576754090259932,0.12751677852348994,0.5527280486983086,1.0,6/34,9.05%,TCF4;ZEB1;AHR;MITF;TAL1;CIART
prerank,protein phosphatase 1 binding (GO:0008157),0.5586494237007866,1.2559434575876696,0.2227342549923195,0.766204598671343,1.0,3/21,4.53%,PPP1R3B;PPP1R3C;SHOC2
prerank,acid-thiol ligase activity (GO:0016878),-0.5163048030825587,-1.2555179092906141,0.18159203980099503,0.5498736913603549,1.0,4/13,10.91%,ACSS3;ACSL1;ACSS1;ACSS2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5477123749571091,1.252653642638653,0.20684523809523808,0.7704900398090845,1.0,8/23,9.97%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,copper ion binding (GO:0005507),-0.40533162761672137,-1.2525207038779116,0.13559322033898305,0.5483459805000641,1.0,7/42,9.16%,PAM;MOXD1;LOXL3;SOD3;SNCA;ATOX1;LACC1
prerank,translation initiation factor activity (GO:0003743),0.5080579200692792,1.2521920247612488,0.1847672778561354,0.7658490750525719,1.0,14/36,20.42%,EIF4G3;EIF4G1;EIF2D;MTIF3;EIF3E;COPS5;EIF4E3;EIF3A;EIF2B2;EIF4G2;AGO2;EIF2S2;EIF2S1;EIF2B3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5610885956424182,1.2513360287770372,0.21840873634945399,0.7627354770147865,1.0,11/21,29.24%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLI;POLM;PRIMPOL
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6086474021919275,1.2507615841827768,0.22984562607204118,0.7586905032970408,1.0,4/12,11.48%,SULF1;ARSI;ARSB;SGSH
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4611865051814717,1.250670249952968,0.18216080402010051,0.7530687252484496,1.0,15/71,8.78%,EYA2;PTP4A2;PTPN3;PTPRU;UBASH3B;EYA4;PTPRF;PTPDC1;PTPN2;PTPRA;CDC25B;EYA3;PTPN21;CDC14A;DUSP11
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5230429919689585,1.2501443128064265,0.1933139534883721,0.7488503000740845,1.0,13/33,17.03%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6194097929862574,1.2500805778962678,0.2440677966101695,0.7432561401088638,1.0,3/12,16.14%,CYFIP2;EIF4E3;AGO2
prerank,death receptor activity (GO:0005035),-0.5244313191807075,-1.2491762344676616,0.20714285714285716,0.5481960966999597,1.0,3/11,7.01%,TNFRSF19;FAS;TNFRSF11A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5508993147014342,1.2479808427994628,0.22061191626409019,0.7439843724981587,1.0,11/20,21.62%,USP25;USP7;USP47;DESI2;COPS5;SENP5;OTUD5;USP9X;USP21;SENP1;SENP3
prerank,DNA polymerase activity (GO:0034061),0.5547857723309145,1.2470557846051629,0.23219814241486067,0.741396221154123,1.0,11/22,29.24%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLI;POLM;PRIMPOL
prerank,cadherin binding (GO:0045296),0.40947896295101316,1.2462172736485095,0.07971014492753623,0.7385142974000793,1.0,78/315,13.67%,EGFR;CDH1;CDH11;FMNL2;BAIAP2L1;TES;STXBP6;CTNND2;FXYD5;EZR;ABI1;AHNAK;NDRG1;ANXA1;ANXA2;CALD1;PHLDB2;MPP7;PARVA;SPTAN1;CTNNA1;GIPC1;PLCB3;ITGB1;PAICS;FLNB;ERC1;CAST;PDXDC1;HDLBP;TMOD3;SNX2;ESYT2;STX5;VCL;CLINT1;SHTN1;CLIC1;PFKP;DLG1;PDLIM5;BZW1;PKP1;JUP;KTN1;RDX;MARK2;SH3GLB2;UNC45A;TXNDC9;P2RX4;IQGAP1;CD46;NIBAN2;ACVR1;EHD1;CTTN;CCS;EMD;CAPZA1;GAPVD1;GOLGA3;PLEC;KRT18;EIF3E;SERBP1;LIMA1;PCMT1;LYPLA2;NOP56;EPS15L1;ADD1;SH3GLB1;BAG3;PKN2;PAK2;ARGLU1;HCFC1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6330062443851112,1.2457998653991544,0.23618090452261306,0.7341702478098507,1.0,1/10,0.85%,DPYSL3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4797087683854649,-1.244617406640431,0.18956043956043955,0.5514440383399704,1.0,9/19,14.92%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,calcium channel inhibitor activity (GO:0019855),-0.5354716804884079,-1.2419955675572574,0.22422680412371135,0.5495223593407974,1.0,3/11,9.70%,ITPR1;CALM1;SLC30A1
prerank,MHC protein binding (GO:0042287),-0.45744353041634916,-1.240930188064369,0.1994949494949495,0.5442243761090769,1.0,8/20,21.72%,ATP5F1B;CD81;TAP2;ATP5F1A;CD74;ABCB9;TUBB4B;TAPBP
prerank,CoA-ligase activity (GO:0016405),-0.4974614960634756,-1.2405966845431375,0.2076923076923077,0.537412346952371,1.0,5/14,15.07%,ACSS3;ACSL1;ACSS1;ACSS2;ACSBG1
prerank,lysine N-methyltransferase activity (GO:0016278),0.5539596276387537,1.2398747088509994,0.2353846153846154,0.7466445901714526,1.0,11/20,27.15%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;METTL21C;SETD6;EEF1AKMT4
prerank,clathrin adaptor activity (GO:0035615),0.5882228588002458,1.2373382009735108,0.23311897106109325,0.7486755114509377,1.0,4/15,9.05%,STON1;STON2;AP2A2;AP2A1
prerank,voltage-gated potassium channel activity (GO:0005249),0.4494624037574303,1.236153944074821,0.18427518427518427,0.7465606881311848,1.0,6/80,3.03%,KCNB2;KCNJ2;KCNQ5;KCNS3;KCNJ15;KCNB1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6169879886136701,1.2312015792543847,0.2563237774030354,0.7563102907508042,1.0,5/10,12.60%,CXADR;DSP;DSG2;JUP;DSC2
prerank,receptor ligand activity (GO:0048018),0.40969160451643977,1.22952624145107,0.11452810180275716,0.7559625083101931,1.0,40/245,11.60%,BMP4;TNFRSF11B;WNT9A;OSGIN2;BMP5;NGF;EDA;PGF;TGFB3;SEMA3E;WNT11;SEMA3D;SEMA3C;BMP6;INHBA;FGF2;LRPAP1;FAM3C;CLCF1;DEFB130A;WNT16;GDNF;PTHLH;JAG1;SLURP1;GDF6;IL10;GDF5;NBL1;PDGFA;IL33;GDF10;CTF1;C1QTNF12;TIMP1;VEGFA;INHBB;TNFSF11;CCL3;ERFE
prerank,phosphatase activator activity (GO:0019211),-0.5076063301543713,-1.2291003965414984,0.1792717086834734,0.5572265834872812,1.0,5/14,14.04%,CALM1;BMP2;FRS2;PPP2R5A;CALM3
prerank,fibroblast growth factor binding (GO:0017134),0.548718008617318,1.2284201728642052,0.24110032362459546,0.7538483028270712,1.0,3/21,5.86%,THBS1;FGFR1;ITGAV
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4434609854235561,1.226400645052137,0.18895705521472392,0.7543402951664623,1.0,19/78,12.26%,CAPN5;USP46;USP2;USP13;CAPN2;USP24;CASP6;CAPN6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;USP47;CAPN10;CAPN12;USP33
prerank,phosphotyrosine residue binding (GO:0001784),0.4958535087823861,1.2222511347741425,0.2157968970380818,0.7620067862904845,1.0,11/37,13.87%,PTPN3;VAV2;SHC1;IRS1;ABL1;NCK2;CBLC;BCAR3;PLCG2;YES1;PIK3R3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.4472639177414168,-1.2182981937869533,0.19174041297935104,0.5755484774291127,1.0,9/24,18.26%,OSBPL8;CERT1;DAB2IP;PLEKHA5;GSDMD;JPH2;RUBCNL;LANCL2;SNX3
prerank,leak channel activity (GO:0022840),0.5507240750880382,1.2168354968950925,0.2289348171701113,0.7734950545979463,1.0,2/18,4.42%,KCNK5;NALCN
prerank,triglyceride lipase activity (GO:0004806),0.5396394116591393,1.214645870915097,0.2459546925566343,0.7745549613404354,1.0,4/20,13.08%,PNPLA3;PLA2G15;DAGLB;LCAT
prerank,SH3 domain binding (GO:0017124),0.4551599120858837,1.2140057359723337,0.2073976221928666,0.7708809315840367,1.0,11/62,9.24%,AFAP1L1;DPYSL3;ABI1;ADAM9;ABL1;ADAM12;PLSCR1;CBLC;SHANK1;RUFY1;AFAP1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.42452323135837666,-1.2135067515958677,0.1930835734870317,0.5793290505177564,1.0,9/28,14.92%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,CoA hydrolase activity (GO:0016289),0.5695803041018065,1.2125932859543975,0.25562700964630225,0.7697945505243459,1.0,9/16,25.42%,ACOT8;HIBCH;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11;NUDT7;ACOT6
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.44420420772230207,1.2116539696041042,0.19548872180451127,0.7672809164869606,1.0,14/72,9.70%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1;SLC9A1;PARD3;COMMD1;FCHO2
prerank,endodeoxyribonuclease activity (GO:0004520),0.5489095759069211,1.2104984167091242,0.273015873015873,0.7659554260764752,1.0,9/20,23.42%,EXO1;ERCC5;APLF;APEX1;RBBP8;ERCC1;RAD50;MBD4;EXOG
prerank,DNA binding (GO:0003677),0.3884352639910294,1.2102707209070651,0.043043043043043044,0.7615468429954603,1.0,160/694,18.83%,FOXP2;EGFR;KLF12;TCF7L1;SIX1;TCF7L2;SLTM;PLAGL1;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;CUX1;FOXO3;HES1;MEOX2;ZBTB16;GRHL1;MPG;COLEC11;ESR2;NFE2L2;ZNF148;CRY2;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;EHF;NR4A3;FOXL1;NR4A2;RNF138;HDGFL3;ARID4A;RBM6;CREBBP;C1D;STAT3;MBD1;E2F3;GATA4;RORA;DDIT3;CEBPZ;IRF1;EXO1;SLPI;TEAD1;MYOG;DMBX1;NOBOX;SOX14;CCDC25;MCM7;GLI2;CAMTA2;ZNF8;STN1;ERCC5;RXRA;FOXC1;GRHL2;EGR2;NFYA;WRN;MCM2;BCLAF1;RARG;GATA1;CTCFL;RAD23B;FOXE1;TOP1;CARF;SMAD2;CHTF18;APEX1;TRIM26;JUN;CLSPN;ZBTB32;IGHMBP2;SMC1A;DDX11;FOXK2;ATF6;BRCA2;CBFB;RAD52;NABP1;ZMYM4;BPTF;NKX2-1;ZC3H12A;SMARCA4;NR6A1;TCF3;KMT2D;CDC45;NR4A1;PRKDC;HNF4A;HNF1A;XRCC5;PAX6;RFX2;CHD3;EP300;E2F2;BCL6;DNMT3A;POLG2;DHX9;MCM9;FOXD2;KIN;THRAP3;TLR8;HINFP;CALCOCO1;PRDM5;ZBTB7A;RBBP8;TFAP2A;POU6F1;TAF4;YY1;ERCC3;ZNF219;XPA;TRIM16;TAF12;RPA1;AIFM2;TOP3A;KHDRBS1;SREBF1;ZNF76;INO80;TSG101;NBN;TSHZ2;RAD51;PPARG;POLR3F;EZH1;CCNT1;DHX36;QRICH1;RFX5;ERCC1;RFC1;NEIL3;AIFM1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5203462325315691,1.2101983492681103,0.25609756097560976,0.7566893891682056,1.0,2/25,2.00%,MICAL2;FMO1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.586594507716722,1.2095560811122985,0.26677577741407527,0.753593139915216,1.0,11/13,37.99%,PNPLA3;LCLAT1;GPAT3;LPCAT1;ABHD5;GPAT4;LPCAT2;AGPAT5;AGPAT2;AGPAT4;AGPAT1
prerank,poly(A) binding (GO:0008143),-0.42820138819316184,-1.2085913067226455,0.23391812865497075,0.583669893753229,1.0,4/21,6.69%,RBPMS;RBMS1;KHDRBS2;ELAVL4
prerank,protein serine/threonine kinase activity (GO:0004674),0.3945767788444314,1.208565314462835,0.10835913312693499,0.7514041773341671,1.0,87/334,17.22%,STK39;EGFR;MAP3K5;GRK5;MARK1;PTK2B;CAMK2D;CIT;WNK1;PRKCD;ULK2;CLK1;ALPK1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;BCR;TGFBR1;CLK2;MKNK2;STK16;SGK3;TGFBR2;STK35;TRIO;IRAK4;GAK;CDK12;RIPK2;IKBKE;FAM20A;VRK3;MARK2;CSNK1A1;CHEK2;PLK3;NLK;CSNK1G3;CHUK;RIPK3;AAK1;SIK3;IRAK3;ATM;AURKA;ACVR1;TOP1;PIM2;MARK3;SIK2;ERN2;MAPK12;MAST2;HTATIP2;CDKL2;CPNE3;PRKDC;PDK3;SMG1;MTOR;CSNK1G1;PKN2;PAK2;CHEK1;PRKCA;CDC42BPG;DYRK2;CSNK1E;EIF2AK4;CDK11B;SQSTM1;CDK16;MAPKAPK2;CLK4;TLK2;NEK6;CDK13;CDC42BPA;NEK8;VRK2;CDK10;ATR;SRPK1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5446873791488789,-1.2081804007671477,0.23205741626794257,0.5771499463496139,1.0,4/10,11.00%,DPP10;DPP4;PRCP;DPP6
prerank,potassium ion leak channel activity (GO:0022841),0.5674668297847584,1.206697298110096,0.2561576354679803,0.7516717872981966,1.0,1/15,0.20%,KCNK5
prerank,chloride channel inhibitor activity (GO:0019869),0.6072963591199294,1.2064962163021742,0.2782462057335582,0.7472986317063558,1.0,2/10,9.20%,WNK1;STX8
prerank,RNA cap binding (GO:0000339),0.5707791892827782,1.204176678087941,0.26721311475409837,0.7490365485341297,1.0,1/16,1.01%,CYFIP2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4243704584614861,-1.2040892058102872,0.2238372093023256,0.5796613648958303,1.0,13/23,17.63%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A;PDE3B;PDE9A;CNP
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.43297834242434896,-1.2033400841652255,0.22413793103448276,0.5742230283699095,1.0,12/21,16.50%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A;PDE3B;PDE9A
prerank,RNA polymerase binding (GO:0070063),0.5511265458584906,1.1994783985008441,0.25120772946859904,0.7574606294848393,1.0,7/18,14.67%,NEDD4;STOM;SCAF8;TCERG1;PKN2;PHRF1;DHX9
prerank,serine-type endopeptidase activity (GO:0004252),0.43951717162631104,1.197685755486724,0.2297979797979798,0.7575648679551292,1.0,3/80,4.73%,F3;PCSK5;PRSS12
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.48786823858777806,-1.1970309215417259,0.25569620253164554,0.5817625377873062,1.0,6/14,18.12%,CTSH;NOD1;MAL;ATP2A3;RACK1;CASP1
prerank,filamin binding (GO:0031005),0.5995146304424442,1.193839451263092,0.27759197324414714,0.7639396232758111,1.0,2/11,6.57%,DPYSL3;NEBL
prerank,NF-kappaB binding (GO:0051059),0.514838372636353,1.1901424298782564,0.2786885245901639,0.76985882573935,1.0,6/24,17.58%,ANXA4;GSK3B;MTDH;EP300;CPNE1;BCL10
prerank,phospholipase C activity (GO:0004629),0.5126172097420899,1.1898711692648671,0.2619392185238784,0.7658318389000971,1.0,8/25,9.97%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,rRNA binding (GO:0019843),-0.37251451381012773,-1.187019723744503,0.17793594306049823,0.5983700026132991,1.0,11/42,17.85%,RPS14;RPS9;RPS13;RPS3;RPS5;RPL23;RPL11;FASTKD2;MRPS11;RPL12;RPL5
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4413836647311797,1.1865147239727152,0.2408575031525851,0.7703746843805407,1.0,4/75,2.13%,ME1;EHHADH;BDH2;ADH7
prerank,single-stranded DNA helicase activity (GO:0017116),0.5382387463726197,1.1863835614109017,0.2796875,0.7659114771022912,1.0,11/19,28.99%,MCM7;MCM2;CHTF18;DHX9;CHTF8;RAD51;HELB;DSCC1;RFC5;POLQ;MCM6
prerank,pre-mRNA binding (GO:0036002),0.49984396569916734,1.1851825150094384,0.2551622418879056,0.7645585400343405,1.0,11/28,25.31%,DDX5;SRSF6;CELF1;CELF3;U2AF2;RNPC3;U2AF1L4;TRA2B;RBM4;ERI1;CELF4
prerank,iron ion binding (GO:0005506),0.46829060185774357,1.1831102293650044,0.2550607287449393,0.7659076039314529,1.0,11/48,17.64%,AOX1;EGLN3;FDX1;FTO;TYW5;SCD;CDO1;ALKBH8;NFU1;JMJD6;ABCE1
prerank,metalloaminopeptidase activity (GO:0070006),0.5677173193948825,1.1765207667725681,0.31385642737896496,0.7801124706571915,1.0,6/16,11.82%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5221302695556231,-1.17647667532199,0.27923627684964203,0.616737946191649,1.0,4/10,10.02%,APOBEC1;ADARB2;LACC1;GDA
prerank,fatty acid synthase activity (GO:0004312),-0.5214739668949148,-1.1757485526416112,0.2562189054726368,0.6113295660814698,1.0,3/10,11.35%,ELOVL7;ELOVL6;ELOVL4
prerank,magnesium ion binding (GO:0000287),0.4022903733464048,1.1742769019452648,0.22727272727272727,0.7817297177308844,1.0,34/135,20.32%,EYA2;MAP3K5;MARK1;GCLC;ABL1;PLSCR1;DXO;MARK2;NLK;WRN;SIK3;IRAK3;SIK2;NUDT5;ERN2;MAPK12;MAST2;FOXK2;HACL1;PLSCR3;CDC42BPG;DYRK2;PDXP;CLYBL;DIS3L2;NUDT12;NEK6;CDC42BPA;SRPK1;DHX36;RHEB;DYRK3;EXD2;RAN
prerank,histone acetyltransferase binding (GO:0035035),0.5226901500644411,1.1720020443640564,0.2852807283763278,0.7834015384224986,1.0,7/21,15.80%,GLI3;MEF2A;BCAS3;KANSL1L;KANSL1;PAX6;ZBTB7A
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5639777263657381,1.1718573418953948,0.3248730964467005,0.7791304431807843,1.0,2/13,12.06%,EHHADH;EBP
prerank,amyloid-beta binding (GO:0001540),0.4273397947956288,1.171037780349681,0.25584255842558423,0.7767609189160067,1.0,9/79,8.94%,COL25A1;ADRB2;LRPAP1;ITM2C;LRP1;LDLR;CLU;TLR4;ATP1A3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5234170312776074,-1.169846053946625,0.2798165137614679,0.6187846828122295,1.0,6/10,14.92%,GABRG3;GABRA2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,tropomyosin binding (GO:0005523),0.5415871144944647,1.1678632096087267,0.30048465266558966,0.7813742632224375,1.0,3/16,6.57%,CALD1;TMOD3;NEBL
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4741862998195902,-1.1678004674714209,0.2770448548812665,0.6167317638614713,1.0,6/14,22.38%,ALDH1L1;BLVRB;ALDH4A1;QDPR;AASS;PYCR2
prerank,calcium ion binding (GO:0005509),0.3804951202344427,1.1677968461601136,0.1488277268093782,0.7770034066710526,1.0,32/323,7.77%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;ACER3;CDH11;ESYT3;PPP3CA;ANXA1;ANXA2;ANXA3;DSPP;GSN;ANXA4;COLEC11;DSG2;GLCE;TRPM4;PLA2G4F;ESYT2;STIM2;LRP1;ITPR2;CASR;PLSCR1;CRACR2A;OC90;TGM3;S100G;SYT8;LTBP4
prerank,sialyltransferase activity (GO:0008373),-0.4283131333881669,-1.165878468993298,0.26243093922651933,0.6138626591823251,1.0,9/20,9.20%,ST6GALNAC3;ST6GAL1;ST3GAL1;ST3GAL6;ST8SIA4;ST3GAL3;ST8SIA6;ST8SIA1;ST6GALNAC2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.3230800311715498,-1.1653113995829447,0.13548387096774195,0.6083486825849638,1.0,15/82,8.96%,COL4A3;TIMP3;SPOCK2;PROS1;SPOCK3;SERPINI1;CST3;ITIH2;SPOCK1;APP;TFPI;BST2;SERPIND1;GAPDH;A2M
prerank,alkali metal ion binding (GO:0031420),-0.4749469821422366,-1.164150786580047,0.2682926829268293,0.6042667806776605,1.0,1/13,0.02%,ATP1A2
prerank,myosin II binding (GO:0045159),0.5850345603052921,1.1640143575516475,0.31993299832495814,0.7832906973020515,1.0,6/10,24.77%,GSN;SHROOM4;TRIOBP;LLGL1;MYL4;STXBP5
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.419870368172733,1.1638369430967848,0.24692874692874692,0.7792150622087143,1.0,17/91,9.70%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1;WIPI2;RLBP1;GBF1;SLC9A1;PARD3;COMMD1;FCHO2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5451479917861911,1.1590679575802063,0.31438127090301005,0.7878125166022576,1.0,3/13,3.23%,SOX9;EZR;GSK3B
prerank,damaged DNA binding (GO:0003684),0.4656380495207264,1.1577912443949503,0.28711484593837533,0.7868211727641068,1.0,15/44,21.35%,MPG;CRY2;CREBBP;ERCC5;APEX1;EP300;RBBP8;ERCC3;XPA;RPA1;NBN;ERCC1;NEIL3;TDG;SMC6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3960691533066202,-1.156703181806239,0.2563291139240506,0.6146202744895438,1.0,6/28,8.89%,PRKAA2;TNK2;MAP2K6;SGK1;RPS6KA1;PAK3
prerank,estrogen receptor binding (GO:0030331),-0.38699726972889154,-1.1563688754741253,0.24172185430463577,0.6086709983563013,1.0,5/32,5.48%,LEF1;TACC1;NCOA1;PPARGC1B;RERG
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3400200621663615,-1.155059544515515,0.22077922077922077,0.6051881609903734,1.0,29/60,15.24%,FLT1;IGF1R;TEK;PDGFRB;MERTK;KIT;EPHA7;TIE1;KDR;EPHB1;INSR;ERBB4;EPHA4;ROR2;EPHB4;EPHA8;EPHA6;NTRK2;FGFR4;FLT4;AXL;PDGFRA;LMTK2;MUSK;TYRO3;EPHA5;CSF1R;ACVRL1;FLT3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4999782522578478,1.153935689329676,0.3091715976331361,0.79306764930504,1.0,4/24,4.82%,PTK2B;CAMK2D;PHKA2;MKNK2
prerank,MAP kinase phosphatase activity (GO:0033549),0.559185273597523,1.1513259763976944,0.30755711775043937,0.7964645979440869,1.0,3/12,11.95%,DUSP5;DUSP16;DUSP10
prerank,ion channel activity (GO:0005216),0.4242847612876739,1.1508916475387885,0.24535315985130113,0.7931751896736822,1.0,12/80,8.07%,PIEZO2;TMEM120A;TMC6;TRPM6;NALCN;TRPM4;TMC1;CALHM5;TRPM7;CALHM2;P2RX2;GRIK4
prerank,voltage-gated ion channel activity (GO:0005244),-0.46196292522183885,-1.1486430197311353,0.2885085574572127,0.6134612574503046,1.0,3/14,3.86%,CACNA1E;KCND2;HCN1
prerank,phosphatidate phosphatase activity (GO:0008195),0.5599141169792023,1.1474845475842337,0.33889816360601,0.7981489780575338,1.0,2/13,2.20%,PLPPR2;PLPP3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5126110791069283,1.1450584336405556,0.3141122913505311,0.8005235260559179,1.0,10/22,16.99%,TAB3;IKBKE;OTUD7B;WDR81;UIMC1;RNF168;ZRANB1;SQSTM1;ZBTB1;IKBKG
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5069779578897162,-1.1435915612996352,0.2982885085574572,0.6191710639444885,1.0,2/10,3.90%,MECOM;PRDM16
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4805188469345322,-1.1416841800806747,0.3080568720379147,0.6166859093870034,1.0,9/12,45.73%,ELOVL4;GPR88;RRH;GPR52;OPN3;OPN5;OPN1SW;GNAT2;OPN4
prerank,CARD domain binding (GO:0050700),0.5393895511799796,1.139275539016207,0.335,0.8116384384505522,1.0,3/14,6.50%,CARD14;MAVS;RIPK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.43635404650393084,1.138513702875279,0.2845744680851064,0.8093104363639477,1.0,13/54,18.84%,ACER3;HDAC4;HDAC9;VNN1;HDAC8;MIER1;NTAN1;HDAC10;NIT2;SIRT6;PIGL;MIER2;NAAA
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4785783115975326,1.1381344587836375,0.30243161094224924,0.8060407067980905,1.0,9/29,17.50%,ABL1;DUSP5;DUSP16;ATF7;DUSP10;TNIP1;MAPKAPK2;NFATC1;NBR1
prerank,protein tyrosine kinase binding (GO:1990782),-0.32414922171020716,-1.136843964705523,0.18974358974358974,0.6222725128596778,1.0,27/71,21.57%,NRG3;DOCK4;GRM5;GRB14;NEDD9;CBLB;EPHA4;SIRPA;ANGPT2;SOCS5;GAS6;BLNK;SHC3;DUSP3;SHC4;NOX4;SH2B3;RACK1;FLT3LG;ARHGEF16;CDH5;TJP2;HYAL2;NRG1;ANGPT4;PHYHIP;TREM2
prerank,WW domain binding (GO:0050699),-0.3945753332438417,-1.1362427279689813,0.27844311377245506,0.6171544038998291,1.0,7/26,15.85%,RAPGEF2;TNK2;LITAF;NDFIP2;TCEAL9;ENAH;DAZAP2
prerank,N-methyltransferase activity (GO:0008170),0.5113419478854422,1.1355164611076811,0.3203125,0.8086730732369749,1.0,4/20,16.63%,RNMT;NNMT;GNMT;METTL15
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5202317171457719,1.1342770840924843,0.32861635220125784,0.8077449262116376,1.0,7/18,10.17%,TGFB3;SMAD6;TGFBR1;TGFBR2;BAMBI;USP15;SMAD2
prerank,snoRNA binding (GO:0030515),0.47421670372730823,1.1321154224314882,0.32344213649851633,0.8094380460434649,1.0,16/30,28.19%,BMS1;NUDT4;NUDT5;UTP6;NOP56;PRKDC;XRCC5;DDX21;WDR3;BYSL;NUDT1;NOP58;NUDT7;IMP4;TSR1;NUDT16L1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.416588505002775,-1.1320672516595491,0.29428571428571426,0.6205048429219169,1.0,8/22,15.68%,SCN7A;HCN1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,neurexin family protein binding (GO:0042043),0.5708291879146696,1.1304834821498813,0.33217993079584773,0.8096383066279028,1.0,2/10,4.49%,SYTL5;SYTL4
prerank,chloride channel regulator activity (GO:0017081),0.5449893827241723,1.1295425131281565,0.34206219312602293,0.8078988064293334,1.0,3/14,9.20%,WNK1;SGK3;STX8
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4625552279469619,1.127961631290315,0.3084648493543759,0.8079145319738396,1.0,12/34,27.15%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;KMT5B;EEF1AKMT1;METTL21A;METTL21C;SETD6;EEF1AKMT4
prerank,single-stranded RNA binding (GO:0003727),0.45268313970184787,1.1279155983229152,0.32833787465940056,0.8037977481250762,1.0,12/43,19.50%,STRBP;ZFR;L1TD1;U2AF2;DDX11;IFIH1;DHX9;TLR8;AGO2;JMJD6;EIF4B;FMR1
prerank,protein phosphatase activator activity (GO:0072542),-0.4624783946474915,-1.1273540013775318,0.3324742268041237,0.6249920757928575,1.0,4/13,14.04%,IGFBP3;CALM1;PPP2R5A;CALM3
prerank,acetyltransferase activity (GO:0016407),0.46867197879490874,1.1246949189118702,0.3251798561151079,0.8081771541620776,1.0,16/31,29.12%,KAT6B;CREBBP;ELP3;PAFAH1B2;LCAT;EP300;KAT2B;NAA15;SAT1;NAA50;NAT10;GTF2B;ESCO1;NAA80;KAT6A;PAFAH1B3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.47585859812515324,1.1229186391555244,0.3272450532724505,0.8090915802919838,1.0,9/28,20.69%,EDA;FEM1B;TNFSF11;MYD88;TRAF5;PIDD1;TRAP1;TRAF3;CASP8AP2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.42540756550313635,1.122163642538528,0.3103448275862069,0.8070800738013298,1.0,11/60,6.37%,EGFR;CRIM1;MET;NTRK3;DDR2;FGFR1;NRP1;IGF2R;EFEMP1;EPHB3;ROR1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5369457480497231,1.1209330941791027,0.34951456310679613,0.8063145856793899,1.0,12/15,37.99%,PNPLA3;LCLAT1;GPAT3;LPCAT1;ABHD5;ABHD4;GPAT4;LPCAT2;AGPAT5;AGPAT2;AGPAT4;AGPAT1
prerank,ankyrin binding (GO:0030506),0.5084235340078382,1.1200767285144768,0.35038759689922483,0.8046440197079067,1.0,1/19,0.33%,CDH1
prerank,growth factor activity (GO:0008083),0.4169906723422081,1.1193819588167697,0.3181818181818182,0.802397236474889,1.0,10/74,8.14%,OSGIN2;NGF;PGF;INHBA;FGF2;CLCF1;GDNF;JAG1;IL10;PDGFA
prerank,telomeric DNA binding (GO:0042162),0.45642425629443606,1.1189328026440202,0.3314203730272597,0.7995412230846912,1.0,12/32,22.27%,SMG6;TELO2;KDM1A;STN1;WRN;APEX1;SMG1;XRCC5;RPA1;UPF2;RAD50;TEN1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.42683259314190275,1.118515551800911,0.3216145833333333,0.7967296495877533,1.0,8/55,6.14%,SLC24A3;PKD1;ATP2C2;ANXA2;PKD2L2;ATP2B4;ITPR2;TRPM7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5348663487663252,1.1146824008756535,0.3242320819112628,0.8034454142168234,1.0,2/14,13.40%,ADH7;RDH12
prerank,calcium channel activity (GO:0005262),0.4031293221352429,1.1139487191963888,0.28660826032540676,0.801388477919749,1.0,17/84,12.27%,SLC24A3;PKD1;CACNA1C;ANXA2;CACHD1;PKD2L2;TRPM4;TMC1;STIM2;ITGAV;TRPM7;CACNG6;CACNA1F;P2RX4;MCU;SEC61A1;ORAI3
prerank,Wnt-activated receptor activity (GO:0042813),0.5201212764882119,1.1104291242661564,0.3408723747980614,0.8064476668758555,1.0,5/15,10.73%,PKD1;FZD7;ROR1;FZD1;LRP5
prerank,BMP binding (GO:0036122),-0.4886903989780409,-1.1102458553275238,0.34772182254196643,0.6595853905074238,1.0,2/11,2.09%,ENG;GREM2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5127285744319467,1.110126189517267,0.3474178403755869,0.8031685366634463,1.0,4/17,10.55%,BDH2;DECR1;PECR;LBR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.45593183120371217,1.1096218644742877,0.31332357247437775,0.8006060394769106,1.0,7/35,16.27%,FOXP1;KLF10;TAF1C;SMARCA4;BAZ2A;AGO2;TAF4
prerank,ubiquitin binding (GO:0043130),0.4099883375491785,1.107212683118108,0.3258426966292135,0.8035013063732555,1.0,25/73,25.45%,NEDD4;USP13;DDI2;RNF185;USP25;RAD23B;USP33;MVB12B;RNF168;CXCR4;NPLOC4;SQSTM1;IKBKG;NBR1;TSG101;WDR48;UBE2N;RNF31;TOM1L1;RBCK1;FAF2;UBAP1;ASCC2;ADRM1;BUB3
prerank,small GTPase binding (GO:0031267),0.3784908287747011,1.1066903317102215,0.29443838604143946,0.8010324607040864,1.0,30/169,10.47%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;MLPH;DOCK7;UNC13B;ERC1;SRGAP2;PDE6D;HPS4;RAB11FIP3;ANKRD27;OCRL;MYCBP2;RAPGEF6;RGP1;EXOC5;RAB3GAP2;FGD6;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4717131929133322,-1.105334816841053,0.3448275862068966,0.6650656444606251,1.0,3/12,1.07%,LTBP1;ENG;TGFBR3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.47453780972233206,1.1046157516865018,0.3675344563552833,0.8027686189333084,1.0,5/26,3.93%,SLC5A6;SLC16A9;SLC16A1;ABCG2;SLC26A6
prerank,potassium channel regulator activity (GO:0015459),0.43228712995263835,1.1022329338732935,0.3301759133964817,0.8054176041038024,1.0,7/49,6.66%,KCNMB2;KCNMB3;WNK1;KCNS3;ADRB2;SGK3;DLG1
prerank,vinculin binding (GO:0017166),0.5508846108725616,1.1016370471395205,0.3606010016694491,0.8030196788939222,1.0,3/11,5.55%,SORBS3;CTNNA1;DMD
prerank,frizzled binding (GO:0005109),0.4551634456064936,1.1010926017291955,0.3196022727272727,0.8004772992986634,1.0,7/34,7.57%,WNT9A;LRP6;WNT11;FZD7;WNT16;BAMBI;FZD1
prerank,chemorepellent activity (GO:0045499),-0.3933093748209737,-1.1000503472257104,0.3103448275862069,0.6710920078626927,1.0,10/25,11.99%,SEMA6A;NRG3;SEMA7A;EPHA7;SEMA6D;DPP4;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5385812557918377,1.0987472542063943,0.37542087542087543,0.8030748522976403,1.0,5/12,17.15%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,transition metal ion binding (GO:0046914),0.3554472631417174,1.0952133069687884,0.2804878048780488,0.8085300265987868,1.0,89/397,16.24%,ME1;AOX1;ACER3;ZFPM2;TES;HDAC4;MPPED2;ADH7;KLF4;NPEPPS;LARGE1;ABL1;HHIP;EEA1;KLF7;SEC24B;FDX1;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;ARIH1;SKI;TIMP2;MNAT1;ZMYND8;MBD1;XPNPEP1;PLA2G15;ADA;B4GALT1;PLSCR1;IDE;XPNPEP3;CBLC;TNP2;MYCBP2;ZMYM2;GLI2;ZNF8;MDM4;RXRA;P2RX4;TYW5;WRN;SCD;LIMS1;COMMD1;SEC23A;TIMP1;CCS;ZBTB32;SCO2;CUTC;ZDHHC15;ADAMTS3;ERAP1;SMPDL3A;CZIB;MSRB2;USP33;ALKBH8;CHORDC1;SEC24D;ARIH2;IFIH1;MMP13;UBA5;TK1;CHD3;PLSCR3;PITRM1;LARGE2;DYRK2;ECE1;NFU1;RNF2;MGAT1;HDAC10;S100B;KDM2A;DPP3;DPEP1;ZDHHC20;NUDT12;SORD;CAD;NSD1
prerank,metal ion binding (GO:0046872),0.35225049711145373,1.0945940771209792,0.2462159434914228,0.8063907967081382,1.0,57/477,11.13%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;EYA2;ACER3;CDH11;MAP3K5;MARK1;ESYT3;PPP3CA;ANXA1;ANXA2;ANXA3;DSPP;GSN;ANXA4;GCLC;COLEC11;DSG2;ABL1;GLCE;TRPM4;PLA2G4F;ESYT2;STIM2;LRP1;ITPR2;CASR;PLSCR1;CRACR2A;DXO;OC90;TGM3;S100G;SYT8;LTBP4;MARK2;NLK;S100A10;IQGAP1;WRN;SIK3;IRAK3;C2CD5;PCLO;S100A2;SIK2;NUDT5;APEX1;TRIM26;ERN2;MAPK12;MAST2;FOXK2;HACL1
prerank,3'-5' exonuclease activity (GO:0008408),0.4330245483597758,1.0944741182476396,0.3568521031207598,0.8028802970504288,1.0,25/45,32.97%,REV3L;ERI3;WRN;APLF;APEX1;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;TATDN1;RAD50;ERI1;ERI2;PARN;EXOSC4;EXOSC2;REXO2;CNOT8;EXOSC3;REXO4;DIS3;EXD1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.41939391736666287,-1.0923132114913734,0.35279187817258884,0.6826804831012481,1.0,3/18,1.07%,LTBP1;ENG;TGFBR3
prerank,endopeptidase regulator activity (GO:0061135),-0.346642922495615,-1.0912433855050716,0.33460076045627374,0.678779544429604,1.0,14/40,22.85%,PROS1;CST3;ITIH2;TFPI;SERPIND1;A2M;APH1B;PSME2;VSIR;UCHL5;ABCA2;HRG;AHSG;ITIH3
prerank,four-way junction DNA binding (GO:0000400),0.4968535058538604,1.0886798790070322,0.35526315789473684,0.8142176666948994,1.0,6/17,21.22%,ABL1;WRN;YY1;FANCM;RAD51B;RAD51C
prerank,calcium-dependent phospholipid binding (GO:0005544),0.42006515957185697,1.0883525275144168,0.35772357723577236,0.8113160470602487,1.0,10/49,10.00%,ESYT3;ANXA1;ANXA2;ANXA3;ANXA4;PLA2G4F;ESYT2;SYT8;C2CD5;PCLO
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5532515896411212,1.0876790395138454,0.3963515754560531,0.8092892862974309,1.0,4/10,21.89%,EXO1;APEX1;EXD2;TATDN1
prerank,pseudouridine synthase activity (GO:0009982),0.5104361439011299,1.087039382123117,0.3927392739273927,0.8071911064792535,1.0,8/13,31.28%,PUS10;RPUSD4;PUS7L;PUSL1;RPUSD1;TRUB2;PUS7;RPUSD2
prerank,exopeptidase activity (GO:0008238),-0.3315669328086333,-1.0861156465545077,0.3263598326359833,0.6848518610031672,1.0,15/50,14.18%,CTSH;ACE;DPP10;DPP4;ENPEP;CTSA;CTSZ;PRCP;ACE2;DPP6;TRHDE;MME;LTA4H;ZMPSTE24;RNPEP
prerank,protein kinase binding (GO:0019901),0.3493202604156543,1.0861122967761125,0.267005076142132,0.805900465066448,1.0,67/479,10.06%,SLC12A7;SLC12A2;TCF7L2;GRK5;PKD1;SOX9;ANK2;CCNA2;EZR;CIT;WNK1;ADAM9;PRKCD;FOXO3;UNC5C;DSP;HDAC9;SHC1;ITGB1;CNTLN;GSK3B;RHOBTB1;IRS1;ABL1;AP2A2;NELL1;SPRED2;NR4A3;ACSL3;TELO2;RNF138;PTPN2;BECN1;DNAJC3;IRAK4;SKI;STAT3;ITGAV;ESR1;MAVS;PFKFB2;NBEA;DLG1;PDLIM5;CDC25B;DUSP5;CHEK2;NSF;IBTK;CDKN1B;RND3;DUSP16;RHOA;IQGAP1;AP2A1;IRAK3;DACT1;TNNI3;LIMS1;AURKA;ACVR1;RB1CC1;RARA;PLCG2;ATF7;PPEF2;PPP1R12A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.45103222250604363,1.0838880168546532,0.36546762589928056,0.8078402471342195,1.0,15/29,27.40%,ACER3;GANC;IDUA;NEU3;HPSE;GALC;GANAB;ENGASE;MGAM;GAA;HYAL3;HEXD;GBA2;NEU1;HPSE2
prerank,voltage-gated cation channel activity (GO:0022843),0.3827662591251753,1.0837479007304562,0.34210526315789475,0.8045845330041699,1.0,11/97,7.40%,KCNB2;CACNA1C;PTK2B;KCNQ5;KCNS3;CACHD1;KCNB1;TMC1;ITGAV;CACNG6;CACNA1F
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4549844513137509,1.083000671912006,0.3776824034334764,0.8028855216323075,1.0,12/34,12.94%,CYTH3;ARAP1;GAB2;ZFYVE1;ARAP2;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;DAPP1;FCHSD2
prerank,protein phosphatase 2A binding (GO:0051721),-0.3960141257254173,-1.0820164336300624,0.3488372093023256,0.6881168396618446,1.0,6/23,8.14%,MFHAS1;FOXO1;DAB2IP;CTTNBP2NL;SPHK1;MAPT
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.4018192568378791,-1.0766413578328393,0.3608815426997245,0.6950764904956048,1.0,6/21,19.82%,GRM5;GRM1;GRIA1;ANXA9;CHRFAM7A;CHRNA7
prerank,histone deacetylase binding (GO:0042826),0.3858724888800475,1.0744331871184987,0.35862913096695226,0.8215598055544256,1.0,33/88,26.48%,HDAC4;GLI3;HES1;HDAC9;MEF2A;LCOR;CAMTA2;DACT1;NCOR1;MIER1;NIPBL;MTA1;KAT2A;NCOR2;PKN2;HDAC10;CCND1;KAT2B;SATB2;MIER2;DHX36;BRMS1L;MAPK8;THAP7;AKAP8L;BEX4;NUDT21;BRMS1;CIR1;MEF2D;TRAF6;RBBP4;PHF6
prerank,kinase binding (GO:0019900),0.3462096984083344,1.069471608209155,0.31781376518218624,0.8306715715861044,1.0,69/434,13.44%,SLC12A7;EGFR;SLC12A2;TCF7L2;PKD1;ANK2;CCNA2;CIT;WNK1;PRKCD;FOXO3;UNC5C;GSN;SHC1;TAX1BP1;CNTLN;GSK3B;RHOBTB1;TTC28;AP2A2;SPRED2;NR4A3;ACSL3;TELO2;RNF138;PTPN2;DLG2;BECN1;DNAJC3;IRAK4;SKI;STAT3;PIP5K1A;ESR1;MAVS;PFKFB2;NBEA;DLG1;CDC25B;CHEK2;NSF;IBTK;BCAR3;CDKN1B;RND3;RHOA;ATP1A4;IQGAP1;AP2A1;IRAK3;TNNI3;LIMS1;AURKA;RB1CC1;PLCG2;PPP1R12A;CAB39;SMCR8;STRADA;PER1;TIAM1;RB1;CARD16;CHP1;FAM83H;NISCH;TRIP6;PRAM1;PAK2
prerank,ADP binding (GO:0043531),0.4633260365594741,1.0692970148530399,0.3963963963963964,0.8273858512245965,1.0,2/25,2.67%,ME1;GCLC
prerank,low-density lipoprotein particle binding (GO:0030169),0.5061509660626985,1.0686202048452478,0.3904761904761905,0.8253047113786858,1.0,2/16,5.84%,THBS1;LDLR
prerank,cysteine-type peptidase activity (GO:0008234),0.3908430207500841,1.0675920194491346,0.3849009900990099,0.8242482467095783,1.0,25/73,20.81%,USP46;USP2;USP13;CAPN2;USP24;CASP6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;USP47;OTUD7B;USP33;CASP2;USP28;USP9X;ATG4A;USP40;ATG4B;USP21;TINAGL1;USP36
prerank,nucleotidyltransferase activity (GO:0016779),0.4885707651405222,1.066443903519716,0.4078125,0.8236725372311613,1.0,7/19,21.84%,PAPSS2;NUDT5;TUT7;TUT4;REV1;MOCS3;TENT2
prerank,vitamin D receptor binding (GO:0042809),0.5053922901815664,1.0645310593840815,0.41830065359477125,0.824929749465197,1.0,6/14,19.78%,RXRA;MED13;MED14;THRAP3;MED24;SNW1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4484533623563065,-1.0605379388720593,0.4004914004914005,0.7289187388156367,1.0,8/13,14.92%,GABRG3;GABRA2;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,actin binding (GO:0003779),0.36060348957568344,1.0599274581697848,0.3713355048859935,0.833078081712682,1.0,36/170,13.85%,MICAL2;COBL;FXYD5;EZR;PHACTR1;PAWR;CALD1;PARVA;GSN;PDLIM7;GIPC1;SORBS1;ITGB1;FLNB;MLPH;PRKCE;ABL1;VCL;MRTFA;DMD;DMTN;PDLIM5;NCALD;RDX;MAP1B;TNNI3;MYOZ3;EMD;CAPZA1;LIMA1;SYNE2;MSRB2;ADD1;PHACTR2;SSH3;CXCR4
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4492428258187971,-1.0494314892469339,0.40594059405940597,0.7489089391994471,1.0,3/12,3.80%,IGF1;PIK3R1;INSR
prerank,MAP kinase activity (GO:0004707),-0.4306825820451595,-1.0493462369853532,0.4077922077922078,0.7423226038320717,1.0,1/14,0.29%,MAPK4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.42973229987347716,1.047877390124179,0.39586206896551723,0.8605638468753581,1.0,5/37,8.71%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5068811915632803,1.0471662205285028,0.41385135135135137,0.8585757755514697,1.0,4/12,10.80%,PGF;ITGA5;VEGFA;ITGB3
prerank,store-operated calcium channel activity (GO:0015279),-0.4700546381188795,-1.0468675597255412,0.4073226544622426,0.7416492077782763,1.0,6/10,15.22%,TRPC3;TRPC4;TRPC6;TRPC1;ORAI2;ORAI1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4701484392783387,1.0468171472647028,0.41896024464831805,0.8557798493714363,1.0,8/20,24.40%,MAGI3;DLG2;DLG1;AK4;AK3;CASK;AK9;AK1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.41910429777622543,-1.0460611162354507,0.3852040816326531,0.7368297404318541,1.0,4/15,13.59%,PIK3R1;PIK3R6;SOCS5;PIK3R5
prerank,platelet-derived growth factor binding (GO:0048407),0.5037693072257375,1.045784661764939,0.40102389078498296,0.8547877366497106,1.0,3/11,8.14%,COL6A1;COL3A1;PDGFA
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4461563756612348,-1.0451686244524654,0.4219512195121951,0.7324196271374238,1.0,5/12,18.12%,CTSH;NOD1;ATP2A3;RACK1;CASP1
prerank,carboxy-lyase activity (GO:0016831),0.46465288268167304,1.0445462002457873,0.43085880640465796,0.8545209023128771,1.0,9/23,23.72%,CSAD;ECHDC1;MVD;PPCDC;AZIN1;ACOD1;UMPS;GGCX;ODC1
prerank,GTPase binding (GO:0051020),0.3539014958741308,1.0444449979470674,0.39092872570194387,0.8511386150419475,1.0,32/194,10.47%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;MLPH;DOCK7;UNC13B;ERC1;SRGAP2;PDE6D;HPS4;BECN1;RAB11FIP3;ANKRD27;RRAGB;OCRL;MYCBP2;RAPGEF6;RGP1;EXOC5;RAB3GAP2;FGD6;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.512495830879435,1.040236870954891,0.4431438127090301,0.8583194066991499,1.0,5/12,14.99%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,sulfotransferase activity (GO:0008146),0.42937348663431746,1.0375042830717751,0.40953716690042075,0.8613061373508456,1.0,5/33,4.64%,UST;HS3ST1;CHST13;CHST5;SULT1A1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.48401530494791184,1.0338250366825046,0.4184168012924071,0.8671905435565842,1.0,3/15,2.85%,HS3ST4;HS3ST1;HS6ST2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5069443779501562,1.032706630313778,0.41983471074380163,0.8663607321543747,1.0,3/12,3.53%,SHC1;GAB2;IRS1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4433304501930557,-1.0298706828156556,0.4360730593607306,0.7636177811720839,1.0,3/10,14.99%,CYBA;NCF2;NOX4
prerank,hormone receptor binding (GO:0051427),0.4940883754834644,1.0284614468233642,0.45310015898251194,0.8733970068637184,1.0,5/14,27.31%,PTHLH;SOCS2;NCOA6;JAK2;VIP
prerank,calcium:sodium antiporter activity (GO:0005432),0.5229505658541358,1.0271214168225165,0.46755407653910147,0.8731759908626082,1.0,1/10,0.69%,SLC24A3
prerank,galactosyltransferase activity (GO:0008378),0.5048664251887891,1.0262230248402153,0.46194690265486726,0.871957542569513,1.0,6/11,20.77%,B4GALT1;B3GALT6;A4GALT;A3GALT2;B4GALT7;B3GNT6
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4739877480613027,1.0236456662932305,0.45741324921135645,0.8745476187620865,1.0,4/17,8.22%,PITPNC1;PITPNA;ATP10A;ATP8B1
prerank,ribosome binding (GO:0043022),0.3977194578998823,1.0230895856497495,0.4360699865410498,0.872393075839337,1.0,12/46,19.50%,RPSA;ETF1;MRPS27;IGHMBP2;MTIF3;SERBP1;SEC61A1;ZC3H12A;EIF6;NAA15;EIF2S1;FMR1
prerank,PDZ domain binding (GO:0030165),0.3839198248353786,1.020878128753846,0.4198473282442748,0.874426818410459,1.0,11/61,8.13%,CRIM1;CIT;CXADR;FZD7;ERC1;SLC26A6;KIDINS220;ATP2B4;FZD1;SNTG2;NSF
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3591675757861808,-1.0202193999181837,0.4,0.7816591059801531,1.0,8/25,20.07%,PARP14;ART3;PARP16;TIPARP;PARP8;PARP11;SIRT5;PARP10
prerank,lipoprotein particle binding (GO:0071813),0.4612893648688206,1.0184404304749552,0.43140243902439024,0.8770171008463856,1.0,2/20,5.84%,THBS1;LDLR
prerank,N-acyltransferase activity (GO:0016410),-0.3385656499441957,-1.0182332120313986,0.4074074074074074,0.7796719494427408,1.0,5/32,12.54%,CERS4;TGM2;NMT2;CERS1;CERS2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3361217982940346,1.0176402197200216,0.4563829787234043,0.8754286523302204,1.0,55/228,18.12%,WWP1;NEDD4;TRAF3IP2;UBE4B;WWP2;RNF144A;RNF115;HERC2;RNF138;UBR4;RNF185;ARIH1;UBR5;MKRN3;TRIM44;RNF19A;TRIP12;RNF114;CBLC;BIRC7;MYCBP2;UBE2D3;RNF126;LRSAM1;UBE4A;KCMF1;TRIM7;TRIM26;RNF111;TRIM41;TRIM55;FBXO17;RNFT2;COP1;RNF122;ARIH2;SMURF1;SH3RF3;ANKIB1;CUL3;RNF2;RNF135;FANCL;UBE2K;ASB1;TRIM39;NSMCE1;RNF14;MKRN1;BFAR;UHRF2;BIRC3;DTX3;UBE3C;MKRN2
prerank,nuclease activity (GO:0004518),0.39821041221721987,1.0171003334536377,0.4540682414698163,0.8731974259937035,1.0,21/52,27.27%,N4BP2;STK31;PLSCR1;EXO1;ERCC5;WRN;APEX1;ERN2;ZC3H12A;RNASEH2A;DIS3L2;DFFB;REXO1;RNASE6;DDX1;RNASE3;EXOG;MAP1S;PARN;RNASE12;RNASE7
prerank,myosin binding (GO:0017022),0.39062728085147347,1.0163205527130013,0.44935064935064933,0.8716618719195266,1.0,10/55,9.32%,CALD1;GSN;GIPC1;MLPH;RAB6A;DMD;NPHS1;SHROOM4;RHOA;RAB25
prerank,phosphatidylglycerol binding (GO:1901611),0.49519361071754653,1.0160514422703328,0.4744645799011532,0.8688379159061068,1.0,2/13,2.62%,PITPNC1;PITPNA
prerank,phospholipase activity (GO:0004620),0.3796855434056881,1.0158343135378443,0.44144144144144143,0.8659216700091532,1.0,13/67,15.84%,PLCE1;MGLL;PLCB3;PNPLA3;PLA2G4F;PLA2G15;ABHD6;DDHD1;SMPDL3A;LYPLA2;LYPLAL1;PITPNM3;SEC23IP
prerank,GDP binding (GO:0019003),0.3817301383451851,1.0150540554829186,0.455,0.8642495140974021,1.0,25/63,28.80%,NRAS;KRAS;MRAS;RAP1A;ARL3;RAP2C;MIEF1;RIT1;RAB27B;RAB21;RAB5B;RHEB;RAB5A;RAN;RAB18;RAB35;RAB11B;RAB7A;RAB42;RAB8A;DIRAS2;RAP2B;RALB;RAB10;RAB17
prerank,hexosyltransferase activity (GO:0016758),0.35924695433795284,1.0144089975782793,0.4272189349112426,0.8624319525521245,1.0,22/101,19.83%,TMTC1;EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;PIGB;A4GALT;B4GAT1;B4GALNT3;LARGE2;POMGNT2;B3GNT9;ALG12;CHPF2;POFUT1;POGLUT2;B4GALT7
prerank,zinc ion binding (GO:0008270),0.3336137706741405,1.0125971298920335,0.48538622129436326,0.8634159801981712,1.0,68/293,16.24%,ACER3;ZFPM2;TES;HDAC4;ADH7;KLF4;NPEPPS;HHIP;EEA1;KLF7;SEC24B;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;ARIH1;SKI;TIMP2;MNAT1;ZMYND8;MBD1;PLA2G15;ADA;PLSCR1;IDE;CBLC;TNP2;MYCBP2;ZMYM2;GLI2;ZNF8;MDM4;RXRA;P2RX4;LIMS1;SEC23A;TIMP1;ZBTB32;ZDHHC15;ADAMTS3;ERAP1;SMPDL3A;CZIB;MSRB2;USP33;ALKBH8;CHORDC1;SEC24D;ARIH2;IFIH1;MMP13;UBA5;TK1;CHD3;PITRM1;ECE1;RNF2;HDAC10;S100B;KDM2A;DPP3;DPEP1;ZDHHC20;NUDT12;SORD;CAD;NSD1
prerank,solute:proton symporter activity (GO:0015295),0.4653882051208481,1.0115272895148746,0.45691056910569106,0.8625763652244129,1.0,1/16,1.15%,SLC2A13
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34679787190941663,1.0112261953757948,0.45787139689578715,0.8599827139441295,1.0,29/147,11.74%,DOCK5;PLCE1;ARHGEF28;CYTH3;AKAP13;VAV2;DNMBP;RASGEF1B;BCR;RAP1A;HERC2;HPS4;ANKRD27;DENND2C;ARHGEF6;MYCBP2;RAPGEF6;RGP1;WDR41;RAB3GAP2;FGD6;DENND6A;ARHGEF10;FARP1;SMCR8;GAPVD1;RANGRF;ARHGEF5;TIAM1
prerank,protein kinase regulator activity (GO:0019887),0.35933573776092065,1.0112043653598621,0.45476190476190476,0.8566765175485629,1.0,16/95,12.22%,CCNA2;WNK1;WNT11;PARVA;FGF13;KIDINS220;DNAJC3;CCNL2;ELP3;MARK2;CDKN1B;CCNL1;CAB39;SMCR8;STRADA;CCNYL1
prerank,NADP binding (GO:0050661),0.4210607538659561,1.0098637990178985,0.44933920704845814,0.8564710572717954,1.0,3/32,6.47%,ME1;GMDS;DECR1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5042018373097052,1.0085089959822462,0.4897959183673469,0.8564300792564795,1.0,9/11,32.23%,PRMT8;PRMT6;CARM1;PRMT5;NDUFAF7;FBXO11;PRMT2;PRMT9;PRMT3
prerank,nuclear localization sequence binding (GO:0008139),0.46039970774674244,1.0054786715978334,0.4570552147239264,0.8604421880144812,1.0,5/18,15.56%,KPNA1;TNPO2;NUP153;KPNA4;NUP214
prerank,"DNA binding, bending (GO:0008301)",0.48777954001979934,1.0049973001561585,0.46798029556650245,0.8582730641987497,1.0,3/14,8.70%,FOXD1;FOXL1;FOXC1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4999412753369036,1.0045592009965538,0.4796084828711256,0.8560537298454208,1.0,4/12,20.77%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,sequence-specific mRNA binding (GO:1990825),0.518806937640739,1.0032070503632973,0.46221441124780316,0.855932796449467,1.0,4/10,21.98%,ETF1;DHX9;FMR1;SSB
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.39925483580272125,-1.0003519464210295,0.45012165450121655,0.8172338594315727,1.0,4/14,14.99%,MICAL1;CYBA;NCF2;NOX4
prerank,beta-tubulin binding (GO:0048487),-0.32741715681729505,-1.0003342277997707,0.47419354838709676,0.8103479337140761,1.0,9/31,18.42%,GJB6;TTLL7;EML4;PDCD5;GABARAPL1;GABARAP;TRPV4;PACRG;DLEC1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3270065520290303,0.9994701131858991,0.45851063829787236,0.861546469919032,1.0,54/254,17.83%,EGFR;SNCAIP;TANK;SMAD6;FHIT;MID1;USP2;USP13;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;ARIH1;SKI;CLU;IKBKE;CHEK2;GPI;NLK;EGR2;HSPA1L;USP25;SMAD2;SLC22A18;JUN;USP7;PER1;RB1;TRAF5;TNFRSF1B;CKB;XRCC5;CXCR4;CUL3;FATE1;NPLOC4;SPOP;TRIOBP;SQSTM1;FANCL;PSMD1;CASC3;UBE2K;AMBRA1;CUL1;PML;NEK6;IKBKG;TSG101;BCL10;PRKAR2A;CDKN1A
prerank,anion transmembrane transporter activity (GO:0008509),-0.41411098056312867,-0.9991254063844179,0.46208530805687204,0.806449743580354,1.0,3/12,4.74%,SLCO2B1;SLC22A6;SLC39A8
prerank,methylated histone binding (GO:0035064),0.3802215101443337,0.9990513726181001,0.4942675159235669,0.8592156481258256,1.0,26/62,31.31%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;SUZ12;PYGO1;FMR1;MORC4;CHD1;THAP7;ING1;SPIN4;CBX8;CBX2;ING3;TAF1;CHD8;MPHOSPH8;NCAPD3;RRP8;GLYR1
prerank,protein kinase inhibitor activity (GO:0004860),0.39503321299839395,0.9969670148468062,0.47928176795580113,0.8608869180348314,1.0,7/42,10.71%,CIT;PARVA;SPRED2;DNAJC3;IBTK;CDKN1B;SMCR8
prerank,methylation-dependent protein binding (GO:0140034),0.38548285968543095,0.9951599766282128,0.4869791666666667,0.8618943392524163,1.0,25/57,31.31%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;SUZ12;PYGO1;FMR1;MORC4;CHD1;THAP7;ING1;SPIN4;CBX8;CBX2;ING3;CHD8;MPHOSPH8;NCAPD3;RRP8;GLYR1
prerank,Hsp90 protein binding (GO:0051879),0.41089976464882827,0.9935371325723541,0.4804630969609262,0.8623413339680691,1.0,7/33,12.45%,SLC12A2;TELO2;HDAC8;UNC45A;PPEF2;PPP5C;CHORDC1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3981354113231088,0.9918575230272256,0.4798890429958391,0.8629609722371526,1.0,19/42,30.20%,CCNA2;CCNL2;CDKN1B;CCNL1;CCNYL1;CCND1;KAT2B;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNE2;CCNF;HEXIM1;CCNT2;CDKN2C;CDKN2D;CKS1B
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4343509039801347,-0.9909831499034296,0.48418491484184917,0.8205030436442867,1.0,3/11,9.14%,LEF1;GATA2;MBD2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.39373259873530747,0.9905814442503189,0.46808510638297873,0.8626689549681404,1.0,7/38,8.89%,SHC1;SORBS1;GAB2;IRS1;NCK2;SHANK1;G3BP2
prerank,single-stranded DNA binding (GO:0003697),0.35628955403655815,0.989998669881127,0.5054945054945055,0.8607918896942836,1.0,29/93,21.35%,CRY2;RNF138;MCM7;STN1;ERCC5;MCM2;RAD23B;TOP1;IGHMBP2;DDX11;BRCA2;RAD52;NABP1;CDC45;DHX9;MCM9;RBBP8;RPA1;TOP3A;RAD51;DHX36;ERCC1;NEIL3;RTF1;WDR48;SWSAP1;RAD51B;POLA1;SMC6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.32651747443064033,0.9893093185689815,0.4962805526036132,0.8592274973203807,1.0,55/232,18.12%,WWP1;NEDD4;TRAF3IP2;WWP2;RNF144A;RNF115;HERC2;RNF138;UBR4;RNF185;ARIH1;UBR5;MKRN3;TRIM44;RNF19A;TRIP12;RNF114;CBLC;BIRC7;MYCBP2;PIAS2;PIAS3;EGR2;UBE2D3;RNF126;LRSAM1;KCMF1;TRIM7;TRIM26;RNF111;TRIM41;TRIM55;FBXO17;RNFT2;COP1;RNF122;ARIH2;SMURF1;SH3RF3;ANKIB1;CUL3;RNF2;RNF135;FANCL;ASB1;TRIM39;NSMCE1;RNF14;MKRN1;BFAR;UHRF2;BIRC3;DTX3;UBE3C;MKRN2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.43040880384081,0.9884007867235564,0.48214285714285715,0.8581834237324679,1.0,13/24,31.97%,IP6K2;PPIP5K2;IP6K1;IP6K3;AK4;AK3;AK9;PPIP5K1;AK1;NME6;AK5;CMPK1;DTYMK
prerank,nuclear export signal receptor activity (GO:0005049),0.48598967503577845,0.9863289874390527,0.4948805460750853,0.8597608423741481,1.0,5/11,23.37%,XPO1;NUP214;XPO4;RAN;XPO7
prerank,kinase activator activity (GO:0019209),0.4157004314493023,0.9849685407991977,0.4773371104815864,0.8599348000128094,1.0,6/30,10.88%,WNK1;WNT11;FGF13;MARK2;CAB39;STRADA
prerank,N-acetyltransferase activity (GO:0008080),0.4406569606735424,0.9818609729770189,0.47433903576982894,0.8638954985845428,1.0,9/19,27.11%,ATAT1;EP300;NAT1;KAT2B;SAT1;NAA50;NAT10;ESCO1;NAA80
prerank,actinin binding (GO:0042805),0.4389014518894838,0.9811272426646619,0.48425787106446777,0.8625041652798459,1.0,9/21,17.93%,CACNA1C;CSRP3;PDLIM5;CSRP2;NFKB1;RARA;MAGI1;PDLIM4;PPARG
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.48599231435959683,0.9807831016335357,0.48639455782312924,0.8601345343170176,1.0,4/11,18.73%,APEX2;APLF;APEX1;NEIL3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3452465792503734,-0.9799465814542987,0.4801223241590214,0.8417811394113647,1.0,11/30,19.04%,SLC30A10;SLC39A10;SLC39A8;SLC40A1;SLC30A1;SLC31A1;SLC30A4;TTYH1;SLC39A1;SLC39A7;ATP7A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3615287690610325,-0.978659249768482,0.49712643678160917,0.8380520897505909,1.0,5/22,12.26%,APOE;PICALM;HSPG2;SYT1;HSP90B1
prerank,calcium-release channel activity (GO:0015278),-0.3796622338893101,-0.9772382191665305,0.5067750677506775,0.8347653518539723,1.0,2/17,4.62%,ITPR1;RYR2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4422276379573983,0.9758314250909069,0.5238828967642527,0.8678102639097931,1.0,8/20,22.31%,PNPLA3;MOGAT3;PLA2G15;MOGAT1;LCLAT1;GPAT3;LPCAT1;ABHD5
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3180823713591307,0.9756746274308792,0.5169133192389006,0.8650563996053476,1.0,55/269,17.83%,EGFR;SNCAIP;TANK;SMAD6;FHIT;MID1;USP2;USP13;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;ARIH1;SKI;CLU;IKBKE;CHEK2;GPI;NLK;EGR2;HSPA1L;USP25;SMAD2;SLC22A18;JUN;USP7;PER1;RB1;TRAF5;DDRGK1;TNFRSF1B;CKB;XRCC5;CXCR4;CUL3;FATE1;NPLOC4;SPOP;TRIOBP;SQSTM1;FANCL;PSMD1;CASC3;UBE2K;AMBRA1;CUL1;PML;NEK6;IKBKG;TSG101;BCL10;PRKAR2A;CDKN1A
prerank,receptor tyrosine kinase binding (GO:0030971),-0.29215043436105115,-0.9751969006502471,0.5132743362831859,0.8331065967484707,1.0,17/56,16.59%,PIK3R1;NRG3;DOCK4;GRB14;CBLB;ANGPT2;SOCS5;FRS2;GAS6;BLNK;SHC3;DUSP3;SHC4;SH2B3;RACK1;FLT3LG;ARHGEF16
prerank,active ion transmembrane transporter activity (GO:0022853),0.401534452560768,0.9747155129690891,0.497907949790795,0.8640908852450396,1.0,3/37,1.51%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,syntaxin-1 binding (GO:0017075),-0.35237608844774726,-0.9743611190865229,0.47878787878787876,0.8285148902715694,1.0,4/22,10.21%,UNC13C;SNAP25;SYT1;SYP
prerank,exoribonuclease activity (GO:0004532),0.4675819175656772,0.9743549886160208,0.4957410562180579,0.8617565374451294,1.0,7/12,31.78%,EXOSC7;ZC3H12A;CNOT7;EXOSC1;EXOSC4;EXOSC2;EXOSC3
prerank,voltage-gated calcium channel activity (GO:0005245),0.38493549166691676,0.9741162737145912,0.5085227272727273,0.8592641526919997,1.0,7/37,7.40%,CACNA1C;CACHD1;CACNA1G;TMC1;ITGAV;CACNG6;CACNA1F
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.41490938405257327,0.9731163341524569,0.49786628733997157,0.8585611254014409,1.0,13/27,33.62%,POLR1A;POLR1F;POLR3K;POLR3A;POLR3F;PRIM1;CRCP;POLR3B;POLR1D;POLR1H;PRIMPOL;POLR1C;MED20
prerank,cell-cell adhesion mediator activity (GO:0098632),0.38422723385514934,0.9724340419398183,0.48010973936899864,0.8570686972980535,1.0,7/42,7.60%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5;EMB
prerank,protein homodimerization activity (GO:0042803),0.3126497259482085,0.971584871407587,0.5727181544633901,0.8560796298523266,1.0,116/589,17.61%,SLIT2;FOXP2;AOX1;EXT1;MAP3K5;ABCD3;LRP6;PDGFC;CAMK2D;MGLL;NECTIN3;HES1;ZBTB16;GRHL1;ABCG2;ADRB2;PRPS2;FGFR1;MID1;CPQ;BMPR1A;GLCE;SRGAP2;EEA1;NR4A3;MYOM3;SNX2;NPR3;ZBTB7B;HPS4;BHLHE40;ACP3;PDCD6IP;RAB11FIP3;NOG;PON3;SPPL2A;STAT3;PNPO;GDNF;XPNPEP1;DDIT3;CASR;RIPK2;IDE;MMACHC;XPNPEP3;CLTRN;JUP;NFS1;CHEK2;PDGFA;RABEP1;PAFAH1B2;ERCC5;S100A10;PRMT8;TYW5;CHUK;WRN;IRAK3;ACVR1;COMMD1;SRM;NRF1;VEGFA;NUDT5;HSPB8;INHBB;CEP131;MVD;MKLN1;CISD2;SLC39A13;SLC8B1;DGCR8;GLB1;CCDC66;ADD1;NR6A1;TCF3;NAGA;ZDHHC2;FBXO4;SH3GLB1;UBA5;GALE;CREB3L3;HNF4A;ECE1;GSTM4;CEACAM5;ST3GAL2;MAD2L1;S100B;KYAT1;CARNMT1;ZBTB1;PML;XDH;TMEM192;ADAM10;XPA;SDCBP2;CEP43;SCARB2;IKBKG;CEP57;KNSTRN;CDADC1;BARD1;PSMD7;STARD3NL;PDLIM4;TSG101;ABCD1
prerank,acylglycerol lipase activity (GO:0047372),0.49319552846980497,0.9705322241894774,0.49393414211438474,0.8553591926817254,1.0,2/11,7.47%,MGLL;ABHD6
prerank,P-type ion transporter activity (GO:0015662),0.4680451769430547,0.968400705894967,0.492436974789916,0.8570483876132833,1.0,2/12,5.23%,ATP2C2;ATP2B4
prerank,water transmembrane transporter activity (GO:0005372),-0.4186082254194893,-0.965353404408796,0.5148063781321185,0.8451218794757508,1.0,2/11,7.82%,AQP11;AQP4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3121102434012708,0.9641636264248403,0.5712809917355371,0.8630022173828589,1.0,96/346,21.97%,WWP1;NEDD4;TRAF3IP2;FBXO10;WWP2;RNF144A;RNF115;HERC2;RNF138;UBR4;RNF185;FBXW8;UBE2B;ARIH1;UBR5;MKRN3;TRIM44;BIRC6;RNF19A;TRIP12;RNF114;CBLC;BIRC7;RNF214;MYCBP2;RNF141;KLHL13;TRIM47;UBE2D3;RNF126;FBXW11;LRSAM1;KCMF1;TRIM7;TRIM26;FBXL6;RNF111;TRIM41;TRIM55;FBXO17;RNF146;UBE2Z;TRAF5;RNFT2;COP1;RNF122;ARIH2;RNF168;SMURF1;SH3RF3;FBXO4;ANKIB1;UBE2S;CUL3;ERCC8;RNF2;RNF135;FANCL;UBE2K;ASB1;TRIM39;CUL1;PML;CHFR;NSMCE1;RNF14;MKRN1;BFAR;UHRF2;BIRC3;BARD1;DTX3;UBE3C;MKRN2;FBXO25;TRIM35;TRAF3;CNOT4;UBE2W;TRIM25;TRIM45;TSPAN17;RNF8;MIB1;UBE2N;RNF31;ANAPC11;RNF123;CDC42;NFX1;RBCK1;UBE2M;PPIL2;CUL4A;HUWE1;RMND5A
prerank,kinase inhibitor activity (GO:0019210),0.3978458961005841,0.9625521947394451,0.5115606936416185,0.8636350284844129,1.0,5/33,10.71%,LRP6;PARVA;DNAJC3;CDKN1B;SMCR8
prerank,aminopeptidase activity (GO:0004177),0.4186633302606607,0.9606745137350484,0.5246636771300448,0.8647231918247387,1.0,7/26,13.86%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1;LAP3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3835892388031394,0.960354532101479,0.5036710719530103,0.8625124347227322,1.0,13/33,19.97%,RNF144A;RNF185;ARIH1;RNF19A;ZMYM2;DCUN1D5;TCERG1;ARIH2;ANKIB1;RNF14;DCUN1D2;DCUN1D1;DCUN1D4
prerank,hydro-lyase activity (GO:0016836),0.37626208859498844,0.9600776186174009,0.5048409405255878,0.8601060464688588,1.0,7/41,11.74%,EHHADH;GMDS;AUH;CYP2S1;ECHDC1;UROC1;TGDS
prerank,kinase activity (GO:0016301),0.3373551866134147,0.956317433271074,0.5305651672433679,0.8651992029398943,1.0,21/109,13.68%,STK39;PAPSS2;GSK3B;ABL1;PIK3C2B;IP6K2;RFK;ETNK1;TRRAP;DGKA;SHPK;PI4KB;HYKK;CCL3;NADK;MTOR;PPIP5K2;PKN2;CHKB;CKB;AGK
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.41120964794910164,-0.9556276225519935,0.5321100917431193,0.8625984871008805,1.0,2/11,13.28%,HCN1;HCN2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4077591935110984,0.9549898378324343,0.519203413940256,0.8652557262936481,1.0,10/27,27.70%,POLR1A;POLR1F;POLR3K;POLR3A;POLR3F;TENT2;CRCP;POLR3B;POLR1D;POLR1H
prerank,DNA replication origin binding (GO:0003688),0.41232158025392796,0.9546030062777583,0.5113122171945701,0.8632190553508644,1.0,6/23,14.80%,MCM7;MCM2;DDX11;CDC45;DHX9;MCM9
prerank,ligand-gated cation channel activity (GO:0099094),0.35153778431987326,0.9536026425940326,0.5340050377833753,0.8624988368543626,1.0,7/75,8.71%,KCNJ2;PTK2B;KCNJ15;TRPM4;P2RX2;GRIK4;P2RX4
prerank,phosphatidylinositol binding (GO:0035091),0.3451179834909186,0.9524640431474903,0.5431034482758621,0.8620355283949838,1.0,14/91,9.70%,TNFAIP8L3;ESYT3;PITPNC1;PITPNA;EEA1;SNX2;SNX24;ESYT2;BCAS3;ZFYVE1;ITPR2;PHF12;PARD3;FCHO2
prerank,thyroid hormone receptor binding (GO:0046966),0.4061501748964048,0.9518739299607095,0.525679758308157,0.8603742173637791,1.0,11/28,18.72%,JMJD1C;TRIP12;MED13;NCOR1;TRIP6;THRAP3;MED24;NSD1;BRD8;GAS2L1;NCOA6
prerank,acyl-CoA hydrolase activity (GO:0047617),0.4472325705871082,0.9517367795250731,0.5169628432956381,0.8577704194731768,1.0,6/17,18.68%,ACOT8;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11
prerank,cardiolipin binding (GO:1901612),-0.429984862293439,-0.9508516835213134,0.5541561712846348,0.8677573760641524,1.0,2/10,12.67%,GSDMD;MME
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3558471971939534,-0.949833434439429,0.5256064690026954,0.8637600077033567,1.0,3/18,7.16%,PIK3R1;PIK3R6;SOCS5
prerank,ion gated channel activity (GO:0022839),-0.3356707097892327,-0.9487523944664277,0.5352112676056338,0.8597013548234375,1.0,9/24,15.69%,ANO4;KCNT2;TTYH2;KCNT1;ANO2;TTYH1;TMEM63B;ANO3;TMEM63A
prerank,phosphatase activity (GO:0016791),0.35228002517332213,0.9450822736992455,0.5246523388116309,0.8687253317888256,1.0,16/73,15.25%,PLPPR2;PLPP3;ALPL;ACP3;NANP;DUSP5;OCRL;DUSP16;DUSP11;LPIN2;DUSP10;PPP5C;PLPP1;PDXP;SBF1;ACP4
prerank,protein kinase C activity (GO:0004697),-0.39017474941388686,-0.9418874873536516,0.5358974358974359,0.8695161805003403,1.0,6/14,11.11%,PRKCH;PRKD1;PRKCB;PRKCQ;PRKCZ;PKN1
prerank,AMP binding (GO:0016208),0.4634673855933057,0.9392450755037753,0.5304054054054054,0.8782856376553629,1.0,2/11,6.45%,MPPED2;PFKP
prerank,adenylyltransferase activity (GO:0070566),0.418732957307967,0.9383556169951085,0.5449010654490106,0.8773092084883385,1.0,3/21,8.34%,NMNAT2;ABL1;NMNAT1
prerank,GABA receptor activity (GO:0016917),0.4270298609942222,0.9383426177947892,0.5170807453416149,0.874440247671409,1.0,2/21,4.01%,GPR156;GABRA3
prerank,1-phosphatidylinositol binding (GO:0005545),-0.37701800432950894,-0.9363800143822892,0.5555555555555556,0.8762445996840301,1.0,4/15,12.03%,EPB41;PICALM;SNAP91;SCARB1
prerank,lipase activator activity (GO:0060229),-0.4109010281000415,-0.9360795095483382,0.5576470588235294,0.8703198955181255,1.0,6/10,31.22%,ARHGAP6;BTK;CCL5;SRC;APOH;CCL8
prerank,cytokine receptor activity (GO:0004896),0.3401683949230387,0.9347929624183977,0.5667506297229219,0.8790193158120662,1.0,7/83,6.29%,F3;IL17RE;IL22RA1;CD44;CMKLR1;IL17RA;IL17RD
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2619657700655619,-0.9338514782925503,0.6243093922651933,0.8692553204685707,1.0,20/74,19.13%,NADK2;DGKB;DGKI;GK;DGKD;PIK3C2A;PANK1;SPHK1;DGKG;PGM2L1;HK2;FAM20C;CHKA;PAPSS1;IDNK;IPMK;IPPK;PIK3CG;DGKE;DGKZ
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4502932602501792,0.9330644464353138,0.5412541254125413,0.8797348364736316,1.0,4/15,13.87%,PIK3C2B;ATM;PI4KB;PIK3R3
prerank,amino acid binding (GO:0016597),-0.30789090463623286,-0.9328240547435669,0.5570032573289903,0.8651810920514169,1.0,10/31,15.88%,GRM7;NOS3;GRIN2B;GRIN1;GLRA1;GLRA3;GRIN3A;ASS1;AGXT;DDAH2
prerank,actin monomer binding (GO:0003785),0.41292969365500654,0.932648242388562,0.5509893455098934,0.8776602919596815,1.0,4/22,5.39%,COBL;PRKCE;ABL1;MRTFA
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3960265488352598,0.932443225250364,0.5526695526695526,0.8751983000613993,1.0,6/32,11.28%,EGLN3;FTO;TMLHE;RIOX2;TYW5;JMJD4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.39768569240544605,0.9321138480175382,0.5230547550432276,0.8730552892970217,1.0,15/28,35.33%,EXO1;APEX1;RPP38;RNASEH2A;AGO2;DROSHA;DBR1;EDC3;ELAC1;NUDT16L1;AGO3;DICER1;POP1;ELAC2;RNASEH1
prerank,deoxyribonuclease activity (GO:0004536),0.44446672319625,0.931058580565014,0.5358306188925082,0.8723136271306434,1.0,6/14,24.80%,ERCC5;APLF;APEX1;DFFB;MBD4;MAP1S
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4480901314508905,0.9310411631064356,0.542713567839196,0.8695451565106473,1.0,2/13,12.72%,EXO1;SLX4
prerank,phospholipase activator activity (GO:0016004),-0.4107938394345435,-0.9290225854549953,0.562200956937799,0.8682846583679408,1.0,6/10,31.22%,ARHGAP6;BTK;CCL5;SRC;STX4;CCL8
prerank,transferrin receptor binding (GO:1990459),0.4724239354945723,0.9282510712644428,0.5320284697508897,0.8725892889645411,1.0,6/10,26.86%,SNX2;CHUK;IKBKG;SNX4;HFE;IKBKB
prerank,RNA binding (GO:0003723),0.2966991042123451,0.9275311847294538,0.794,0.871149386608821,1.0,404/1321,25.69%,STRBP;MSI2;RNMT;SLTM;MBNL1;SAMD4A;SPATS2L;TES;FNDC3A;DDX5;RPSA;RBFOX2;EZR;AHNAK;EIF4G3;ANXA2;ZCCHC24;GPATCH8;DSP;PURG;HOXB6;TCF20;CTNNA1;RBM47;YBX3;FLNB;LARP1B;GOLGB1;POLR1G;CAST;ERI3;TDRD3;DIAPH1;HDLBP;BMS1;SREK1;LUC7L2;SMG6;SON;DDX17;EIF4G1;VCP;FNDC3B;PNISR;SIDT2;SNTB2;NUFIP2;ANKHD1;RBM6;SRSF11;ALG13;LRP1;C1D;PRR3;ZC3H7A;STAT3;MKRN3;THOC2;DUSP14;KDM1A;SRSF5;ZFR;SYNCRIP;KMT2C;CEBPZ;EWSR1;ZCCHC7;SRRM2;FASTKD1;YARS1;NUDT4;SRSF6;CELF1;BZW1;MOV10;FAM120C;HNRNPH1;DXO;SLPI;MBNL2;KIF1C;CELF3;RBM39;KTN1;RDX;SCAF8;MARK2;PABPC4;FUS;ZC3H14;LARP4B;RBM27;ZC3H18;DDX18;DDX19B;CCDC9;DUSP11;G3BP2;TYW5;RBMS3;WDR43;EBNA1BP2;BCLAF1;RBM25;L1TD1;PCBP4;ETF1;RBMX;DDX43;MTO1;GSPT1;ATXN2;TOP1;ELP5;MRPS27;USP10;MTDH;U2AF2;CS;LBR;PRRC2C;NUDT5;APEX1;TCERG1;JUN;RRBP1;IGHMBP2;SMC1A;RBM28;DDX11;RBM33;ZCCHC8;CISD2;PLEC;KRT18;CKAP4;RPP38;EIF3E;SERBP1;MRPL32;MRPL14;ZBED4;EXOSC7;ARCN1;DDX42;PABPC1;MRPL40;UTP6;DGCR8;AATF;NOP56;TDRD9;NCOA5;ZC3H12A;ALKBH8;PPRC1;EIF3A;CPNE3;ADD1;SCAF11;BRIX1;RPF1;SRRM1;SNRNP70;TRIP6;PRKDC;IFIH1;SMG1;ANXA7;GTPBP4;NIP7;PKN2;FARSA;NELFE;ABCF1;PUM2;XRCC5;MRPS31;TDRD7;CHD3;ZC3H12D;CSNK1E;STAU1;PUS10;EIF2AK4;DHX57;RBM34;TUT7;FYTTD1;DHX9;PRPF3;PUM1;CDK11B;GPKOW;BAZ2A;DCP1A;NOL11;HNRNPM;SCAF4;KIN;THRAP3;TLR8;SF3B2;SF3B1;CASC3;RPUSD4;SEC63;NOA1;SEC23IP;CHTOP;PDCD11;TRMT10A;EIF4G2;AGO2;U2SURP;EIF2S2;CDK13;DDX56;DDX21;YY1;NAA15;ANKRD17;PPIG;MKRN1;MRPL21;JMJD6;DDX49;PDAP1;PRPF38B;MEX3A;MRPL42;KHDRBS1;TUT4;DIDO1;SRPK1;BARD1;EXOSC1;MTIF2;ZC3H15;MRPS30;YLPM1;NQO1;PUM3;UTP4;PSMC1;SNRNP40;ZC3H12C;ANXA11;RBM14;WDR3;SNRNP35;MKRN2;TRAP1;KRI1;EIF2S1;DHX36;USO1;MTHFSD;LSM14B;SRSF2;FXR2;DALRD3;DROSHA;LSM2;ESF1;THOC5;LSM8;TASOR;CAPRIN1;EIF4B;KCTD12;ZC3H11A;WBP4;CNOT4;RRP1B;FDPS;RTF1;CIRBP;PNLDC1;HELB;FMR1;GANAB;TRIM25;SNW1;MRPS35;MRPS28;NXF1;LARP4;PNN;PCDHGA9;MYEF2;MATR3;RAN;DAZAP1;URB1;UBE2N;FAM133B;SRSF12;SEPSECS;IMMT;YTHDF2;TRA2B;USP36;BYSL;ALKBH5;DDX1;NFX1;ILF2;STXBP1;NUP98;ERH;PCDH20;DCAF13;RBM3;DBR1;FBRSL1;NKAP;MAZ;HMGN2;LGALS3;EPRS1;UBAP2L;LACTB2;NUDT1;SRPRA;NOL3;UTP11;MCAT;HUWE1;SSB;NOP58;KNOP1;FLNA;NANOS2;LLPH;FTSJ3;FIP1L1;WDR75;R3HDM2;NAF1;DHX29;ZCRB1;FASTKD5;PRPF40B;DDX24;AKAP8L;SAMD4B;TNRC6A;SRRT;NCBP3;FAM32A;CSTF1;TRUB2;RBM4;NOC3L;RRP36;TRMT1L;HTATSF1;TARDBP;UBTF;NOM1;RBM5;YTHDF3;MRPL10;NUDT7;TAF15;NVL;NUDT21;IREB2;DHX8;UBE2O;PTPN1;LSM4;NPM3;RC3H2;ZFR2;DNAJC21;MRM1;RPL22L1;SUGP1;LUC7L;ERI1;EDC3;RCAN3;NAT10;MCRS1;RBM4B;PRRC2A;PPIL4;CDC40;PTCD1;MRPL20;CELF4;MECP2;CPSF7;R3HDM1;PSMD4;METAP2;HNRNPA2B1;SRP19;CHERP;IMP4;HNRNPUL1;CPSF3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4412296989015003,0.9228816051852382,0.555366269165247,0.8774297815251472,1.0,7/13,31.06%,TRMT10A;TARBP1;METTL1;TRMT1L;TRMT11;THUMPD2;FTSJ1
prerank,voltage-gated chloride channel activity (GO:0005247),0.47193863592114405,0.9222034794004724,0.5711805555555556,0.8760326559077639,1.0,2/10,11.79%,ANO6;CLCN5
prerank,pyridoxal phosphate binding (GO:0030170),0.4124402219189282,0.9220544536749831,0.5525040387722132,0.8735371951055555,1.0,2/20,5.83%,PYGB;PNPO
prerank,chemokine binding (GO:0019956),0.3845667587800672,0.9208465992621929,0.5594713656387665,0.873105788194496,1.0,5/30,13.85%,ITGB1;FGF2;ITGAV;ITGB3;CXCR4
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3905970801907207,-0.9196761785071129,0.5960099750623441,0.8838916148817293,1.0,4/13,6.08%,PDGFD;PDGFRB;IL1R1;ERN1
prerank,glycine binding (GO:0016594),-0.39869458258162016,-0.9177880484581532,0.5673758865248227,0.8815824931937544,1.0,5/11,13.71%,GRIN2B;GRIN1;GLRA1;GLRA3;GRIN3A
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4589022999540623,0.9173388021616304,0.5801393728222997,0.8772915230389441,1.0,4/10,19.83%,B4GALT1;B3GALT6;A3GALT2;B4GALT7
prerank,microtubule binding (GO:0008017),0.3049974929041751,0.9171646738103072,0.6549520766773163,0.8749123576477889,1.0,49/222,18.00%,EZR;NDRG1;CLIP4;MAPRE2;RP1;KIF13A;MID1;MTUS1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;KIF1B;PAFAH1B1;ARL3;KIF1C;GAS2L2;TOGARAM1;KIF9;CAPN6;MAP1B;MACO1;FBXW11;DYNC1I1;KIF7;KATNB1;KIF16B;MAST2;CCDC66;CHP1;TUBGCP6;RMDN3;POLB;RMDN1;KRIT1;TUBGCP5;HOOK3;FAM161A;KIF3B;TUBGCP4;CEP44;CEP295NL;CEP57;KNSTRN;WHAMM;GAS2L1;MAP6
prerank,epidermal growth factor receptor binding (GO:0005154),0.39266733086615047,0.9169124328672559,0.5687789799072643,0.8726702586436952,1.0,8/25,10.78%,SHC1;EFEMP1;SNX2;PLSCR1;AGR2;CBLC;ATXN2;ARF4
prerank,cGMP binding (GO:0030553),0.45520079653314716,0.9168076396966275,0.5631578947368421,0.8701632347409771,1.0,2/11,5.72%,PDE5A;PDE10A
prerank,protein heterodimerization activity (GO:0046982),0.3091857239092568,0.9164981134891595,0.6273637374860956,0.8680968140791789,1.0,30/178,12.78%,KCNB2;EXT1;ADRA1B;ATP1B1;KCNB1;ITGB1;BMP6;HEXA;MEF2A;AGTR1;NR4A2;SNX2;PAFAH1B1;BHLHE40;DDIT3;PDGFA;TLR4;SAE1;PAFAH1B2;ATP1A1;CHUK;IRAK3;AURKA;KATNB1;SMC1A;ATF6;ERBB2;ADD1;TCF3;NR4A1
prerank,histone demethylase activity (GO:0032452),0.39465443448764603,0.9163180208305791,0.5620328849028401,0.8657246053012458,1.0,9/27,18.25%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;JMJD6;HR;FBXL19
prerank,GTPase activity (GO:0003924),0.30973545846586936,0.9146052508567308,0.656554712892741,0.8663651838699785,1.0,28/192,14.35%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAB43;RAB6A;RAP1A;ATL2;GNL1;RHOQ;GNG8;RRAGB;RAP2C;RND3;RHOA;GNA13;GSPT1;RIT1;ENTPD7;GFM2;GTPBP4;GPN1;RAB24;GNAS
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4047467672587155,-0.9131707250437396,0.5721040189125296,0.8861695297505341,1.0,2/10,7.36%,KDM7A;KDM2B
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.43139215197439307,0.9118412440350766,0.5586319218241043,0.8693353302902731,1.0,6/15,31.53%,KMT2C;KMT2D;WDR82;KMT2A;SETD1B;ASH2L
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.35748466768336384,0.9114270068198957,0.5783783783783784,0.8674704124157671,1.0,14/49,16.99%,TAB3;VCP;IKBKE;RAD23B;OTUD7B;WDR81;UIMC1;TNIP1;RNF168;ZRANB1;SQSTM1;ZBTB1;ZFAND6;IKBKG
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4403901425931674,0.9071086609364031,0.5566666666666666,0.8730623773755996,1.0,5/11,28.19%,NUDT4;NUDT5;NUDT1;NUDT7;NUDT16L1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3210167565703349,0.9036372848537371,0.5969084423305588,0.8770045517728691,1.0,33/100,21.82%,CYTH3;ARAP1;PLEKHA4;GAB2;PLCZ1;WIPI2;SNX24;ZFYVE1;ARAP2;RLBP1;GOLPH3;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;SNX12;DAPP1;FCHSD2;ARFIP1;ARFIP2;ANXA8;ATG2A;SNX20;OSBPL5;SNX13;ZFYVE19;WDR45B;PLA2G4A;MYO10;PLEKHF1;RUBCN;ZFYVE26
prerank,cAMP response element binding (GO:0035497),0.45248652058377226,0.9012139687790489,0.5714285714285714,0.8790148446926643,1.0,5/10,14.72%,NR4A3;ATF7;JUN;CREB3L1;ATF2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3906357353257227,-0.9010660548310613,0.6141176470588235,0.9078800704675051,1.0,5/12,25.47%,TBPL1;STAT1;GTF2A1;RUVBL2;RELA
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36860674031498125,0.9010580728408478,0.5936139332365747,0.8766661070628791,1.0,4/35,4.60%,PLCE1;MPPED2;PLCB3;APEX2
prerank,exonuclease activity (GO:0004527),0.3531284200007183,0.897716438372677,0.5940860215053764,0.8803689166787682,1.0,12/46,17.24%,REV3L;APEX2;EXO1;DXO;WRN;APLF;APEX1;EXOSC7;ZC3H12A;CNOT7;REXO1;EXOSC1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4135250216917806,0.8965966178250195,0.5897435897435898,0.8798372405303154,1.0,2/19,1.78%,EFNA5;ABI1
prerank,transcription coregulator binding (GO:0001221),0.3483744657029114,0.8965225563001123,0.6114058355437666,0.8773526849294615,1.0,14/50,19.11%,CIT;ZBTB16;ESR1;RORA;LCOR;EHMT1;PER3;PER1;EED;SUZ12;ZBTB7A;NEK6;EHMT2;PER2
prerank,phosphatase inhibitor activity (GO:0019212),0.39968399921121317,0.893695399854144,0.603125,0.8803300562547368,1.0,9/20,25.24%,CABIN1;STYXL1;BOD1L1;URI1;MGAT5;ARPP19;LGALS3;STYX;PPME1
prerank,protein kinase activator activity (GO:0030295),0.3372173357010065,0.8925719585937222,0.6128205128205129,0.8798032573864912,1.0,10/60,10.88%,ABI1;WNK1;WNT11;FGF13;FAM20A;MARK2;IQGAP1;MLST8;CAB39;STRADA
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3731701649531852,0.891468682563891,0.5863708399366085,0.8792489685106653,1.0,11/27,19.97%,RNF144A;ARIH1;RNF19A;ZMYM2;DCUN1D5;ARIH2;ANKIB1;RNF14;DCUN1D2;DCUN1D1;DCUN1D4
prerank,protein tyrosine kinase activity (GO:0004713),0.3133847575702098,0.8907891711164247,0.6733490566037735,0.8780689515277508,1.0,12/108,6.37%,EGFR;MET;NTRK3;PTK2B;DDR2;FGFR1;CLK1;HIPK1;ABL1;FRK;EPHB3;ROR1
prerank,guanyl ribonucleotide binding (GO:0032561),0.29893573722768446,0.8905516671330085,0.6911447084233261,0.8758821151144363,1.0,21/196,8.86%,RHOJ;MPPED2;ATL3;PDE5A;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAB6A;RAP1A;ATL2;PDE10A;GNL1;RHOQ;ARL3;ARF3;RRAGB;RAP2C;RND3;RHOA
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.27066583827269586,-0.8901814333061523,0.6317829457364341,0.9257267317054365,1.0,6/49,10.15%,ATP1A2;ENPP6;SAMHD1;PXYLP1;DUSP23;PTPRO
prerank,endonuclease activity (GO:0004519),0.3511912165152739,0.8885698987810535,0.6062992125984252,0.877074515634067,1.0,14/49,23.77%,N4BP2;SMG6;ERCC5;APLF;APEX1;ERN2;ZC3H12A;ZC3H12D;AGO2;ZC3H12C;LACTB2;MBD4;EXOG;YBEY
prerank,growth factor receptor binding (GO:0070851),0.32030566896934365,0.8864507175042073,0.645933014354067,0.8785262376638617,1.0,20/95,13.54%,PGF;PDGFC;SHC1;FGF2;EFEMP1;SNX2;ITGA5;PLSCR1;AGR2;IL10;CBLC;PDGFA;ATXN2;VEGFA;ARF4;ITGB3;ERAP1;FGF22;TRIP6;PIBF1
prerank,steroid hydroxylase activity (GO:0008395),0.41868719108166275,0.8837726122542839,0.6,0.8811946174984985,1.0,2/16,5.14%,CYP1B1;CYP2S1
prerank,ephrin receptor binding (GO:0046875),0.38256035343325734,0.8830542744408513,0.5932203389830508,0.8799840394030982,1.0,3/21,3.58%,EFNA5;SHC1;ABL1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.36265082404982746,0.882978006380585,0.6221264367816092,0.8775684917704872,1.0,15/38,21.82%,PLEKHA4;PLCZ1;WIPI2;ZFYVE1;PARD3;KIF16B;SNX12;ATG2A;SNX20;SNX13;ZFYVE19;WDR45B;PLA2G4A;PLEKHF1;ZFYVE26
prerank,lipoprotein particle receptor binding (GO:0070325),-0.30889718746096045,-0.8808132442585059,0.6858006042296072,0.9404457473292777,1.0,7/27,17.22%,APOE;PICALM;HSPG2;SYT1;HSP90B1;APBB1;RELN
prerank,carboxylic acid binding (GO:0031406),-0.2819651430562067,-0.8805874866377574,0.6350877192982456,0.9343747786165629,1.0,16/38,24.41%,GRM7;NOS3;GRIN2B;MAG;GRIN1;GLRA1;GLRA3;GRIN3A;PSAP;PHYH;GLDC;CASTOR1;SESN1;GLUD1;NOS2;SHMT2
prerank,cytokine receptor binding (GO:0005126),-0.2429348162083959,-0.8785931475704866,0.7474747474747475,0.9324307224630681,1.0,14/83,13.41%,IL34;TGFBR3;CSF1;IL13RA1;CXCL12;IL6R;OSMR;SPRED1;IL18;IL6ST;SDCBP;MIF;LIFR;CCL19
prerank,death domain binding (GO:0070513),0.4373137283330288,0.8780884258894919,0.6082474226804123,0.8838807874223334,1.0,2/11,3.17%,CRADD;DAPL1
prerank,LRR domain binding (GO:0030275),0.4210653804666799,0.8778311137171186,0.5971107544141252,0.8817930599820019,1.0,6/14,14.21%,PAWR;ERC1;MRTFA;DDIT3;AATF;ZXDC
prerank,nucleoside-triphosphatase activity (GO:0017111),0.29102173568166256,0.8752164481757778,0.721102863202545,0.883967329048592,1.0,38/248,14.67%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAB43;RAB6A;RAP1A;ATL2;VCP;GNL1;RHOQ;CLU;GNG8;KIF1C;RRAGB;RAP2C;RND3;CHD1L;KLC1;RHOA;VWA8;DYNC1I1;GNA13;GSPT1;RIT1;TDRD9;ENTPD7;GFM2;GTPBP4;GPN1;RAB24;CHD3;GNAS;DHX9
prerank,nucleotide diphosphatase activity (GO:0004551),0.4225664896668018,0.8738691668720505,0.6246006389776357,0.8837240562560289,1.0,4/14,16.01%,FHIT;NUDT4;NUDT17;NUDT12
prerank,phosphatidic acid binding (GO:0070300),0.3927207519663487,0.8736962850380989,0.620845921450151,0.8815305842878136,1.0,4/19,9.65%,MARK1;PITPNC1;RAPGEF6;COMMD1
prerank,lipase activity (GO:0016298),0.3407507821522397,0.8728123283300594,0.6524822695035462,0.8805054915833526,1.0,11/43,19.74%,MGLL;PNPLA3;PLA2G15;ABHD6;DAGLB;DDHD1;LCAT;PITPNM3;SEC23IP;LDAH;ABHD2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35630387174923306,0.8708515671540862,0.6126255380200861,0.8814384621367041,1.0,19/34,32.48%,ERI3;PAN3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI1;ERI2;PARN;EXOSC4;EXOSC2;REXO2;CNOT8;CNOT1;EXOSC3;DIS3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.43773435817641726,0.8698955931675713,0.6120996441281139,0.8806188279550008,1.0,6/10,30.13%,CDKN1B;KAT2B;CDKN1A;HEXIM1;CDKN2C;CDKN2D
prerank,carboxypeptidase activity (GO:0004180),-0.2864046255320983,-0.8698955174551434,0.6542056074766355,0.9454326746193606,1.0,5/35,9.88%,AEBP1;AGBL4;CTSA;CTSZ;ACE2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.328000993342231,-0.8697660872789785,0.6368715083798883,0.939214348068102,1.0,7/20,17.34%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,metalloexopeptidase activity (GO:0008235),0.33880583485469234,0.8694494015325994,0.6450742240215924,0.8789180715794704,1.0,15/51,17.57%,NPEPPS;CPQ;MMP16;XPNPEP1;XPNPEP3;CPA5;MMP14;CPA4;CPA3;AGBL3;ERAP1;LAP3;CPB1;DPEP1;METAP1D
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.45135773354718806,0.8692384778933393,0.6329787234042553,0.8768071793758053,1.0,3/10,13.87%,PIK3C2B;ATM;PIK3R3
prerank,nuclear receptor coactivator activity (GO:0030374),-0.26461246190073207,-0.8670313490449394,0.7030567685589519,0.9387972084990693,1.0,12/52,15.83%,TACC1;NCOA1;PPARGC1B;ETS1;PRKCB;PPARGC1A;ELK1;PKN1;ACTN4;CNOT9;MED1;NCOA7
prerank,C-C chemokine receptor activity (GO:0016493),-0.3200174949024275,-0.8660014644520222,0.6363636363636364,0.9347251674505206,1.0,1/21,1.78%,CCR9
prerank,DNA secondary structure binding (GO:0000217),0.3468174755340365,0.8654963202448908,0.6207407407407407,0.8809375873901194,1.0,10/31,21.22%,ABL1;ERCC5;WRN;CLSPN;RBBP8;YY1;FANCM;NEIL3;RAD51B;RAD51C
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.421044592117313,0.8654869685605079,0.6174957118353345,0.8784676676963822,1.0,3/11,22.65%,SLC25A25;SLC19A1;SLC25A17
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.3187600364863262,-0.8624537761725392,0.6761363636363636,0.9359191332378861,1.0,7/22,21.36%,CPEB2;HNRNPA0;ELAVL4;EXOSC9;CPEB3;ELAVL3;RBM24
prerank,C-C chemokine binding (GO:0019957),-0.316299485052127,-0.8623605987175255,0.6714697406340058,0.9298361598418653,1.0,1/22,1.78%,CCR9
prerank,translation elongation factor activity (GO:0003746),-0.3518612076721669,-0.8618818468370965,0.6378896882494005,0.9247540264451415,1.0,2/14,5.65%,EEF1A1;EEF1B2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3740350691433134,-0.8612171817033921,0.6473429951690821,0.9200785058065096,1.0,9/11,45.16%,DDAH2;ARG2;PADI2;DDAH1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,mRNA binding (GO:0003729),0.2841821832440098,0.8607758933117422,0.7387198321091291,0.88441146616494,1.0,63/249,20.74%,SAMD4A;DDX5;RBFOX2;EIF4G3;RBM47;YBX3;HDLBP;LUC7L2;AUH;EIF4G1;THOC2;SRSF5;SYNCRIP;SRRM2;SRSF6;CELF1;DXO;SLPI;CELF3;SCAF8;PABPC4;LARP4B;G3BP2;RBMS3;RBM25;PCBP4;ETF1;RBMX;SERBP1;PABPC1;ZC3H12A;EIF3A;SNRNP70;ANGEL2;PUM2;TDRD7;ZC3H12D;FYTTD1;DHX9;PUM1;DCP1A;HNRNPM;SF3B1;EIF4G2;AGO2;EIF2S2;KHDRBS1;PUM3;ZC3H12C;RBM14;SNRNP35;DHX36;LSM14B;FXR2;THOC5;ZC3H11A;CIRBP;FMR1;LARP4;MYEF2;DAZAP1;YTHDF2;TRA2B
prerank,phosphate ion binding (GO:0042301),-0.3813778242761784,-0.8603072298042114,0.6323185011709602,0.916298703043292,1.0,6/10,29.85%,PDE2A;RPH3A;ADSS1;CHST14;RELA;PNP
prerank,miRNA binding (GO:0035198),0.36187749442069295,0.859020988278689,0.6347305389221557,0.8849779589038036,1.0,12/30,25.50%,ZC3H7A;ZC3H12A;PUM2;TUT7;PUM1;AGO2;DDX21;TUT4;FMR1;MATR3;RBM4;HNRNPA2B1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.30098991099097044,-0.858215654906945,0.6804733727810651,0.9144031601274576,1.0,2/26,2.60%,AEBP1;AGBL4
prerank,MHC class II protein complex binding (GO:0023026),0.42482880933453054,0.856618503756019,0.6224137931034482,0.8867255268220054,1.0,1/11,1.56%,ATP1B1
prerank,nuclear import signal receptor activity (GO:0061608),0.4112253055572072,0.8564829654474057,0.6525974025974026,0.8844561846358288,1.0,5/15,25.63%,KPNA1;TNPO2;KPNA4;TNPO3;IPO4
prerank,dynactin binding (GO:0034452),0.426767998697415,0.8558368193075788,0.6417657045840407,0.8831855979334122,1.0,2/12,5.11%,GSK3B;PAFAH1B1
prerank,3'-5' DNA helicase activity (GO:0043138),0.3958108702227931,0.8547150013806817,0.6286644951140065,0.8827828960785498,1.0,7/16,18.43%,MCM7;WRN;MCM2;DHX9;ERCC3;RECQL5;FANCM
prerank,ferrous iron binding (GO:0008198),0.3811848703948393,0.8542160956104643,0.6384266263237519,0.8811942090299271,1.0,3/21,11.01%,EGLN3;FTO;CDO1
prerank,semaphorin receptor binding (GO:0030215),0.37638644241248453,0.8539836548136094,0.6463414634146342,0.8791918933142874,1.0,3/23,2.46%,SEMA3E;SEMA3D;SEMA3C
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.32253505972257734,0.8538423861766116,0.6714659685863874,0.8770677108461719,1.0,11/60,13.35%,PPP3CA;PPM1H;PPP1R3C;PPTC7;PHLPP2;CDC14A;PPEF2;CDKN3;PPP5C;ILKAP;PPM1A
prerank,bHLH transcription factor binding (GO:0043425),0.3926908221842272,0.8511696040182306,0.6414790996784566,0.8795223428735788,1.0,6/19,15.16%,BHLHE40;CREBBP;ISL1;KDM1A;TCF3;TWIST1
prerank,glutamate receptor binding (GO:0035254),-0.3234096591515595,-0.8493743508828354,0.6735751295336787,0.9267855623803971,1.0,4/17,10.05%,SHANK3;IGSF11;CAMK2A;HIP1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4089252352787549,0.8479172379045793,0.6407942238267148,0.8824499582147834,1.0,6/12,29.90%,TNFSF11;TRAF5;TRAP1;TRAF3;TRAF6;BABAM2
prerank,phospholipase A2 activity (GO:0004623),0.3682707050649858,0.8415677707218381,0.654490106544901,0.8901282155655663,1.0,3/26,6.36%,PNPLA3;PLA2G4F;PLA2G15
prerank,titin binding (GO:0031432),0.39777432381864536,0.8395936173516837,0.6560402684563759,0.8910285506364569,1.0,1/13,1.69%,CAMK2D
prerank,motor activity (GO:0003774),-0.24879712048274477,-0.8382901703742335,0.799163179916318,0.943089928183933,1.0,17/60,19.43%,STARD9;MYO6;MYH9;KIF3C;KIF6;KIFC3;MYL6;KIF26A;KIF26B;KIF1A;KIF5C;KIF21B;DYNLRB1;GPR88;KIFC2;KIF11;DNAH3
prerank,mannosyltransferase activity (GO:0000030),0.36933736148636914,0.8379902420857968,0.672360248447205,0.8912937634836368,1.0,1/21,0.83%,TMTC1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.36777193830193966,0.8376193847347654,0.6602870813397129,0.8894744643769525,1.0,5/22,16.10%,ATP2C2;ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.23450026250721145,-0.8368903207705394,0.87,0.9397921133794874,1.0,20/73,20.09%,LGR4;NPR1;CALCRL;CYSLTR1;BDKRB2;CYSLTR2;PTH1R;SORCS2;SORCS3;GPR37;APLNR;SORCS1;GPR37L1;LGR5;LHCGR;VIPR2;EDNRB;TSHR;RXFP1;INPP5K
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2986084483471578,-0.8362955559094735,0.6914285714285714,0.9350147469392246,1.0,4/21,10.83%,KL;FGF1;FRS2;FGF7
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3647603048587005,-0.8330922904477961,0.6345291479820628,0.9354290818661131,1.0,5/10,19.72%,CASP4;CFLAR;CASP3;CASP1;CASP12
prerank,G protein-coupled receptor activity (GO:0004930),-0.20282454316358467,-0.8313719176478869,0.8636363636363636,0.9327104438554324,1.0,49/239,19.57%,ADGRL4;ADGRL3;PDGFRB;GRM3;ADGRV1;LGR4;GRM5;LPAR1;GRM1;NPR1;CALCRL;ADGRE5;RORB;ADGRB3;P2RY14;TAPT1;ADRA2A;GRM8;P2RY1;ADGRG1;ADORA2A;S1PR1;CYSLTR1;BDKRB2;CYSLTR2;PTH1R;LPAR2;ELOVL4;S1PR3;GPR37;ADGRB1;GABBR2;APLNR;XPR1;GPR88;HRH1;GPR157;NTSR2;ADGRE1;ADGRA1;GPR176;GPR37L1;LGR5;ADGRB2;LHCGR;VIPR2;TSHR;RXFP1;NPFFR2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.317644105286549,-0.8307377781518748,0.7134670487106017,0.9282876918069317,1.0,13/18,43.97%,HSD17B7;HSD17B10;HSD11B1;HSD17B1;HSD17B14;SRD5A2;HSD17B8;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3
prerank,retinoid X receptor binding (GO:0046965),0.4057968394532907,0.8302945080469623,0.6827586206896552,0.8993753217282564,1.0,6/11,18.72%,NR4A2;RARG;NSD1;NRIP1;PPARG;NCOA6
prerank,hyaluronic acid binding (GO:0005540),-0.36365879305786397,-0.8294315372288784,0.6735159817351598,0.9252293999038833,1.0,2/10,4.42%,CEMIP;LAYN
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4158268090545356,0.8291473445393633,0.6655290102389079,0.8987833339244494,1.0,2/10,7.40%,CACNA1C;CACNA1F
prerank,ribosomal small subunit binding (GO:0043024),-0.3178924722087996,-0.8284655218940573,0.7441860465116279,0.9212754683772574,1.0,7/17,25.28%,CPEB2;NPM1;PIM1;EIF4H;DDX3X;NME1;EIF1B
prerank,SH2 domain binding (GO:0042169),0.34615480049170655,0.8282080845479446,0.7041847041847041,0.8979655417808418,1.0,6/31,9.38%,IRS1;ABL1;NLK;RUFY1;AFAP1;ARHGAP5
prerank,ribosomal large subunit binding (GO:0043023),-0.35976297741786056,-0.8267884782056353,0.6977886977886978,0.9187094411320132,1.0,3/11,12.33%,CPEB2;CPSF6;NPM1
prerank,phospholipase binding (GO:0043274),-0.3400365839056192,-0.8260879796945161,0.6829896907216495,0.9144503096056364,1.0,4/13,20.26%,ARHGAP6;BLNK;BTK;SYK
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4128539518905703,0.8246703206420598,0.6712564543889845,0.9012104395466078,1.0,5/11,28.54%,NAA40;NAA15;NAA50;NAA80;NAA60
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3401956143511164,0.8243092986390365,0.6890156918687589,0.8994054176762986,1.0,16/34,30.53%,UBE2B;BIRC6;UBE2F;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2W;UBE2N;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.40805661699706247,0.8240726733185981,0.6469565217391304,0.897440317492114,1.0,5/11,25.98%,ALDH3A1;RDH12;DHRS13;AKR1B10;AKR1B1
prerank,double-stranded RNA binding (GO:0003725),0.3064596079513249,0.8239777357094468,0.6965174129353234,0.8952317981188886,1.0,14/70,19.50%,STRBP;MBNL1;SIDT2;ZFR;MTDH;DGCR8;IFIH1;DHX9;TLR8;AGO2;DHX36;DROSHA;EIF4B;FMR1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.36129829815040243,-0.8231144648979519,0.7020316027088036,0.9140660668235059,1.0,2/10,6.07%,SHANK3;IGSF11
prerank,single-stranded telomeric DNA binding (GO:0043047),0.40444112568939955,0.8223792534149914,0.6514886164623468,0.89541968638477,1.0,4/11,25.50%,STN1;RPA1;RAD50;HNRNPA2B1
prerank,GTP binding (GO:0005525),0.27838515002172226,0.8219724796553219,0.8094194961664841,0.8937141563807497,1.0,18/172,8.86%,RHOJ;ATL3;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAB6A;RAP1A;ATL2;GNL1;RHOQ;ARL3;ARF3;RRAGB;RAP2C;RND3;RHOA
prerank,pyrophosphatase activity (GO:0016462),0.3193120920094679,0.8209194111124496,0.7244623655913979,0.8930791223744184,1.0,10/50,14.99%,ENTPD6;ALPL;NUDT4;DXO;NUDT5;ENTPD2;ENTPD7;PLPP1;DHX9;NUDT15
prerank,ubiquitin-specific protease binding (GO:1990381),0.37703224080210107,0.8197002085248909,0.6871165644171779,0.8927526179828285,1.0,2/19,6.98%,VCP;LCOR
prerank,transaminase activity (GO:0008483),-0.36565959639925577,-0.8191070079974507,0.7182741116751269,0.9158959916596198,1.0,6/11,33.54%,AGXT;GOT2;ABAT;GOT1L1;AADAT;BCAT1
prerank,alpha-actinin binding (GO:0051393),0.35621339380143946,0.8187075990088185,0.6712749615975423,0.8920022057700436,1.0,7/24,17.93%,CACNA1C;PDLIM7;PDLIM5;RARA;MAGI1;PDLIM4;PPARG
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.3507050130483321,-0.8179530219193252,0.6712962962962963,0.9126741765688058,1.0,6/11,23.55%,CASP4;CFLAR;CASP3;CASP1;CASP12;PYCARD
prerank,ATPase activator activity (GO:0001671),0.3692930132853421,0.8170689449416896,0.6911544227886057,0.892260555465951,1.0,4/20,14.90%,ATP1B1;TOR1AIP1;DNAJC1;DNAJA2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3932139868149893,0.8170139983139821,0.6851851851851852,0.8900227122717876,1.0,3/12,22.65%,SLC25A25;SLC19A1;SLC25A17
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.37939651560805265,0.8161828809967148,0.6798732171156894,0.8890045951742559,1.0,9/17,31.97%,AK4;AK3;AK9;AK1;NME6;CLP1;AK5;CMPK1;DTYMK
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.29928718546343863,0.8107592360857487,0.76,0.8952349094736836,1.0,21/69,21.86%,SOAT1;KAT6B;CREBBP;MOGAT3;PLA2G15;ELP3;HHAT;ZDHHC15;DGAT2L6;ZDHHC2;EP300;MOGAT1;ZDHHC20;KAT2B;NAA15;CERS6;CERS5;PLA2G4A;ZDHHC12;NMT1;MCAT
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.33894283348187043,0.8093154261249769,0.7155297532656023,0.8951764533149456,1.0,15/31,30.53%,UBE2B;BIRC6;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2W;UBE2N;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3534690230968216,0.8083949013896625,0.6793048973143759,0.8942696188656019,1.0,5/22,14.88%,DUSP5;DUSP16;DUSP10;CDKN3;SBF1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.391431306764402,0.8072021070230181,0.7008264462809918,0.8937192725002414,1.0,3/15,20.14%,PLA2G4F;PLA2G2C;PLA2G4A
prerank,mRNA 3'-UTR binding (GO:0003730),0.2951184202775094,0.8067219823817011,0.7484355444305382,0.8922113259974727,1.0,29/79,27.02%,DDX5;YBX3;AUH;CELF1;PABPC4;LARP4B;RBMS3;PCBP4;SERBP1;PABPC1;ZC3H12A;ANGEL2;PUM2;PUM1;DHX36;FXR2;CIRBP;FMR1;LARP4;DAZAP1;RBM4;TARDBP;NUDT21;HNRNPA2B1;PARN;EXOSC4;RNF20;SECISBP2L;MEX3D
prerank,transcription coactivator binding (GO:0001223),0.35493794298066916,0.8058609428670785,0.6875,0.8912163935776936,1.0,3/20,6.37%,CIT;ESR1;RORA
prerank,glycerophospholipid flippase activity (GO:0140333),-0.3516609383083541,-0.8045359712766208,0.7036144578313253,0.9308913114817939,1.0,6/11,17.47%,ABCA4;ATP8A1;ABCB4;ATP10B;ATP8A2;ATP11C
prerank,peptide hormone receptor binding (GO:0051428),0.41167455199767045,0.8043446548704845,0.6666666666666666,0.8912818119850495,1.0,2/11,17.39%,PTHLH;GNRH1
prerank,adenyl ribonucleotide binding (GO:0032559),0.2647535413118608,0.8042470765881923,0.8520833333333333,0.8891500751847677,1.0,37/291,11.49%,ME1;MAP3K5;ABCD3;MARK1;MPPED2;WNK1;SMC4;GCLC;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;EIF4G1;MKNK2;PDE10A;PFKP;IDE;CARS2;P2RX2;MARK2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;IRAK3;ACVR1;TOP1;SIK2;ERN2;IGHMBP2;MAST2;HACL1;MIEF1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3622025685082952,0.8041419339720269,0.6942148760330579,0.8870631119529354,1.0,3/21,8.71%,GLRB;P2RX2;P2RX4
prerank,voltage-gated anion channel activity (GO:0008308),0.3793910084759704,0.8024780391243261,0.6755485893416928,0.8874094810573832,1.0,2/15,11.79%,ANO6;CLCN5
prerank,tRNA methyltransferase activity (GO:0008175),0.36861702505359606,0.7978637843956415,0.710077519379845,0.8921898180360409,1.0,10/16,34.35%,ALKBH8;TRMT13;TARBP1;TRDMT1;THUMPD2;FTSJ1;TRMT12;METTL2B;METTL2A;TRMT44
prerank,TBP-class protein binding (GO:0017025),-0.29045534647158155,-0.7952514232470996,0.773109243697479,0.9413495890056195,1.0,9/21,23.69%,AHR;RUVBL1;HHEX;DRAP1;GTF2A1;RUVBL2;PSMC5;DR1;THRA
prerank,protein phosphatase regulator activity (GO:0019888),-0.23419905934926943,-0.7935791283737255,0.875,0.938727284979447,1.0,11/53,14.04%,PPP2R2B;PPP1R16B;CALM1;PPP4R4;DMPK;PPP1R15B;PPP2R5A;LMTK2;SET;PPP2R2C;CALM3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3220601740445267,0.7912897789166626,0.7345767575322812,0.8998568887927375,1.0,18/33,32.48%,ERI3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI1;ERI2;PARN;EXOSC4;EXOSC2;REXO2;CNOT8;XRN1;EXOSC3;DIS3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.32335010955244353,0.7911874516084854,0.7265193370165746,0.8977510710864771,1.0,8/38,17.58%,ANXA2;SERPINB9;SLPI;SERPING1;SERPINE2;SERPINB7;SERPINA2;SERPINB8
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.25584557288241194,0.79038817619728,0.9165818921668362,0.8968034672349259,1.0,51/431,11.13%,MAP3K5;ABCD3;MARK1;RHOJ;WNK1;SMC4;ATL3;NRAS;KRAS;MRAS;PRPS2;N4BP2;BMPR1A;RHOBTB1;TLK1;ABL1;BMS1;TGFBR1;RAB6A;RAP1A;ATL2;EIF4G1;MKNK2;GNL1;RHOQ;ARL3;PFKP;IDE;ARF3;CARS2;P2RX2;RRAGB;MARK2;RAP2C;NLK;RND3;P2RX4;RHOA;ATP1A3;ATP1A1;HSPA1L;SIK3;IRAK3;ACVR1;TOP1;SIK2;ERN2;ARF4;IGHMBP2;MAST2;HACL1
prerank,Toll-like receptor binding (GO:0035325),-0.3443014551287471,-0.7901660862545962,0.7337962962962963,0.9387775640084689,1.0,2/11,6.30%,DAB2IP;UNC93B1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3414955197443572,0.7841396291071,0.7348837209302326,0.9038098120216479,1.0,10/23,21.98%,HNRNPH1;PABPC4;RBMS3;U2AF2;PABPC1;DIS3L2;KHDRBS1;FMR1;DAZAP1;SSB
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.30986264321393686,0.783594094675224,0.7675962815405046,0.9023488609312214,1.0,12/44,20.61%,SMYD2;KMT2C;SETD2;EHMT1;EED;KMT2D;SETD5;NSD1;KMT5A;EHMT2;ASH1L;KMT5B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.32712973088577024,-0.7823981300552378,0.7355371900826446,0.9457199478510636,1.0,6/15,18.26%,PLEKHA5;JPH2;PHLDA3;RUBCNL;LANCL2;SNX3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3349533085072882,-0.7822615009782014,0.75177304964539,0.9404898283130049,1.0,2/11,4.47%,KSR1;SH3RF1
prerank,tRNA binding (GO:0000049),0.31098941793456764,0.7801619530123777,0.7476882430647291,0.9051264636244913,1.0,16/43,27.84%,TYW5;ELP5;MRPS27;IGHMBP2;ALKBH8;EIF2AK4;RPUSD4;TRMT10A;DALRD3;SEPSECS;SSB;NAT10;PTCD1;FARS2;TRNAU1AP;XPOT
prerank,ATP hydrolysis activity (GO:0140603),-0.2480112267565534,-0.7796900549789888,0.8333333333333334,0.9388981269634474,1.0,11/41,19.30%,ABCA4;RHOBTB3;KIF26A;RNF213;ATP2B1;RUVBL1;MYO18A;ABCB10;RUVBL2;ABCD2;DDX3X
prerank,snRNA binding (GO:0017069),0.31217083583976407,0.7790521262620315,0.7547945205479452,0.9045044606924989,1.0,14/42,28.13%,SNRNP70;SNRPB2;LSM11;RNPC3;DDX21;SNRNP35;CCNT1;LSM2;LSM8;LSM4;SF3B3;NCBP2;HEXIM1;CCNT2
prerank,peptidase activator activity (GO:0016504),0.34681212245358195,0.7772597209641356,0.7249240121580547,0.9050495567377853,1.0,2/22,4.92%,TANK;VCP
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.30997816780148946,0.7768613621294453,0.7471428571428571,0.9034246584910361,1.0,7/35,12.80%,PTK2B;CLK1;ABL1;FRK;SRMS;CSK;YES1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.339182343012404,0.772069823599884,0.7434402332361516,0.9081643958590633,1.0,5/23,10.93%,PLEKHA4;WIPI2;GBF1;COMMD1;KIF16B
prerank,tubulin binding (GO:0015631),0.2521849413315265,0.7700419534740346,0.890625,0.9088658786036056,1.0,56/295,18.00%,EZR;NDRG1;UNC5C;MAPRE2;RP1;KIF13A;MID1;MTUS1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;NLRP5;TBCE;BCAS3;KIF1B;PAFAH1B1;TTLL2;ARL3;SETD2;KIF1C;GAS2L2;NCALD;TOGARAM1;KIF9;CAPN6;MAP1B;MACO1;DYNC1I1;KIF7;EMD;KATNB1;KIF16B;MAST2;BRCA2;CCDC66;CHP1;TUBGCP6;RMDN3;POLB;RMDN1;KRIT1;TUBGCP5;HOOK3;FAM161A;KIF3B;TUBGCP4;CEP44;CEP295NL;CEP57;WHAMM;INO80;GAS2L1;MAP6
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.31148016484247887,0.7678660720919079,0.7434842249657064,0.9097631700068505,1.0,18/35,35.71%,FTO;TRMT13;PUS10;DUS1L;TRDMT1;MTFMT;QTRT1;ELAC1;FTSJ1;TRMT12;TRPT1;DUS4L;PTRH2;GATC;ALKBH1;QRSL1;ELAC2;DUS2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3429552207957064,0.7678170769938492,0.7354838709677419,0.9054005953259648,1.0,2/16,3.78%,ANO6;ANO9
prerank,intracellular chloride channel activity (GO:0061778),0.3429552207957064,0.7678170769938492,0.7354838709677419,0.9054005953259648,1.0,2/16,3.78%,ANO6;ANO9
prerank,Hsp70 protein binding (GO:0030544),-0.26437053938251553,-0.7673182345113717,0.8286604361370716,0.9523579819852198,1.0,11/31,28.00%,ERN1;RPS3;SACS;SNCA;GPR37;PACRG;DNAJC10;HIKESHI;FICD;CYP2E1;RNF207
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3477881194707278,0.7671794046448576,0.7549019607843137,0.9018771200716996,1.0,4/16,16.10%,ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3477881194707278,0.7671794046448576,0.7549019607843137,0.9018771200716996,1.0,4/16,16.10%,ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3154345404369962,0.7616091179947618,0.7608370702541106,0.9073799336489219,1.0,9/30,17.21%,CAST;SERPINB9;BIRC6;BIRC7;UBE2Z;CARD16;PRDX5;DPEP1;BIRC3
prerank,peptidase inhibitor activity (GO:0030414),0.3204587117652284,0.7613978093716276,0.7790530846484935,0.9054864625130602,1.0,6/33,12.21%,GPC3;CAST;TIMP2;SLPI;TIMP1;RENBP
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2784367048403224,-0.7610496273387478,0.7960526315789473,0.9457334706504699,1.0,5/22,15.64%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,serotonin receptor activity (GO:0099589),-0.2784367048403224,-0.7610496273387478,0.7960526315789473,0.9457334706504699,1.0,5/22,15.64%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2784367048403224,-0.7610496273387478,0.7960526315789473,0.9457334706504699,1.0,5/22,15.64%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.32815426396014435,-0.7610193462282369,0.746268656716418,0.9405315583109334,1.0,1/11,4.05%,SLC22A4
prerank,regulatory RNA binding (GO:0061980),0.3092988774557582,0.7588142851933625,0.7759336099585062,0.9068032491190624,1.0,11/38,20.32%,ZC3H7A;ZC3H12A;PUM2;TUT7;DHX9;PUM1;AGO2;DDX21;TUT4;FMR1;MATR3
prerank,muscle alpha-actinin binding (GO:0051371),0.35185716145257323,0.755718940460821,0.7533557046979866,0.9088706313487752,1.0,2/15,6.69%,PDLIM7;PDLIM5
prerank,tau protein binding (GO:0048156),0.3039054931621615,0.7550584275582565,0.7700680272108843,0.907648546676477,1.0,9/40,14.89%,MARK1;GSK3B;CLU;MARK2;MARK3;SMAD2;PPP5C;EP300;S100B
prerank,hexosaminidase activity (GO:0015929),0.36894151478919807,0.7533664566380343,0.7579831932773109,0.9077148966647427,1.0,7/12,25.10%,HEXA;SPAM1;NAGA;OGA;CEMIP2;HYAL3;HEXD
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.33208953402370683,0.7532576668193929,0.7757575757575758,0.9056934110346901,1.0,7/25,12.94%,PLEKHA4;GAB2;ZFYVE1;COMMD1;KIF16B;DAPP1;FCHSD2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.32075052591689307,-0.7512807689820497,0.7804878048780488,0.9494191256597997,1.0,4/12,19.46%,SLC38A5;SLC6A6;SLC3A2;SLC36A2
prerank,FMN binding (GO:0010181),0.37792517711389473,0.7502782370418721,0.7413479052823315,0.9075011907176379,1.0,3/11,13.80%,IYD;PNPO;PPCDC
prerank,myosin V binding (GO:0031489),0.3565101268837878,0.7485460163589851,0.75,0.9075991930060524,1.0,6/15,28.80%,RAB6A;RAB25;RAB27B;RAB11B;RAB8A;RAB10
prerank,CXCR chemokine receptor binding (GO:0045236),0.3681365922129135,0.7453174635967997,0.7517482517482518,0.9097279559841351,1.0,2/11,8.68%,YARS1;CXCL2
prerank,ribonuclease activity (GO:0004540),0.2884729721709272,0.7446851667104446,0.8160621761658031,0.908460362051056,1.0,20/56,27.27%,SMG6;ERN2;EXOSC7;ZC3H12A;ZC3H12D;CNOT7;RNASEH2A;DIS3L2;AGO2;EXOSC1;ZC3H12C;RNASE6;LACTB2;RNASE3;EXOG;YBEY;CPSF3;RNASE12;EXOSC4;RNASE7
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3016152297318123,-0.744647943395216,0.7657894736842106,0.9531532776843769,1.0,5/15,25.37%,CCR9;CCR5;CX3CR1;GPR17;CCRL2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.35415480143893785,0.7315810454405232,0.7541528239202658,0.923752928696401,1.0,2/13,11.29%,ARHGDIB;ITGB1BP1
prerank,ATP binding (GO:0005524),0.24128917220021923,0.7289287094159345,0.935856992639327,0.9249739610706421,1.0,32/266,11.13%,MAP3K5;ABCD3;MARK1;WNK1;SMC4;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;EIF4G1;MKNK2;PFKP;IDE;CARS2;P2RX2;MARK2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;IRAK3;ACVR1;TOP1;SIK2;ERN2;IGHMBP2;MAST2;HACL1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3035278496244185,-0.7239729428351895,0.8325242718446602,0.974460440970927,1.0,2/13,5.84%,PIP5K1B;PIK3C2A
prerank,signal sequence binding (GO:0005048),-0.23309317751852648,-0.7217076713566521,0.8992805755395683,0.9718179438774065,1.0,2/35,2.81%,CEMIP;PEX5L
prerank,adrenergic receptor binding (GO:0031690),0.336868748694265,0.7204739719755304,0.7983739837398374,0.9335760108485229,1.0,1/16,1.49%,NEDD4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3579149430798666,0.7194999422295809,0.7768166089965398,0.9326283348291415,1.0,1/11,2.94%,SGMS2
prerank,poly(U) RNA binding (GO:0008266),0.3212546244421897,0.7183111555741061,0.8120063191153238,0.931942343209462,1.0,9/20,21.98%,HNRNPH1;PABPC4;RBMS3;PABPC1;DIS3L2;KHDRBS1;FMR1;DAZAP1;SSB
prerank,endopeptidase activator activity (GO:0061133),-0.31386771144799286,-0.7141319990797508,0.7975903614457831,0.9755074996827957,1.0,3/10,16.03%,APH1B;PSME2;VSIR
prerank,G protein-coupled receptor binding (GO:0001664),0.24690625870586727,0.7121154400849988,0.9195922989807475,0.9372969703837223,1.0,14/132,12.26%,WNT9A;LRP6;WNT11;FZD7;AGTR1;PDCD6IP;WNT16;BAMBI;FZD1;GNA13;PROK2;USP4;HOMER2;USP33
prerank,general transcription initiation factor binding (GO:0140296),-0.24877469664456436,-0.7048550879536405,0.9099099099099099,0.9806869218820912,1.0,10/25,25.47%,AHR;RUVBL1;HHEX;DRAP1;GTF2A1;RUVBL2;PSMC5;DR1;THRA;RELA
prerank,5'-3' exonuclease activity (GO:0008409),0.3415064604708151,0.7040336667058925,0.8126036484245439,0.9449025105733633,1.0,2/14,7.03%,EXO1;DXO
prerank,microtubule motor activity (GO:0003777),0.26965480778471757,0.6995215198735072,0.8753387533875339,0.947707254844283,1.0,8/51,10.93%,KIF13A;KIF1B;KIF1C;KIF9;DYNC1I1;KIF7;DNAH8;KIF16B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24739618889125908,-0.6957933779792845,0.8871951219512195,0.9850377168769977,1.0,4/24,10.76%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9
prerank,gamma-tubulin binding (GO:0043015),0.3029999590284518,0.6945430956212952,0.8361669242658424,0.9512136142077111,1.0,5/21,16.55%,NDRG1;BRCA2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,hormone activity (GO:0005179),-0.20663430868845045,-0.6874723354762807,0.9543726235741445,0.9880087536136853,1.0,8/54,17.48%,IGF1;EDN1;SST;PENK;AGT;VGF;METRNL;METRN
prerank,endoribonuclease activity (GO:0004521),0.2889574380373592,0.6862224483410447,0.8526170798898072,0.9580546413800279,1.0,10/32,25.69%,SMG6;ERN2;ZC3H12A;ZC3H12D;AGO2;ZC3H12C;LACTB2;EXOG;YBEY;CPSF3
prerank,methyl-CpG binding (GO:0008327),-0.24904014196416513,-0.6815264008428603,0.8789625360230547,0.9882259652290426,1.0,5/22,17.92%,CXXC4;CXXC5;MBD2;PRMT1;WDR77
prerank,ATPase regulator activity (GO:0060590),0.2788856958488993,0.6794404214984227,0.8846153846153846,0.9631854587218897,1.0,6/38,14.90%,ATP1B1;TOR1AIP1;DNAJC1;KATNB1;BAG3;DNAJA2
prerank,pentosyltransferase activity (GO:0016763),0.27759507981159137,0.6764408903122611,0.8782234957020058,0.9642451915874451,1.0,10/36,20.17%,LARGE1;QPRT;UPP2;TNKS2;LARGE2;PARP3;SIRT6;PARP6;UMPS;PARP4
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.29891259004131676,0.6724759539190999,0.8415384615384616,0.9662276010066957,1.0,5/21,18.02%,EZR;AKAP9;PRRC1;ACBD3;ARFGEF1
prerank,alpha-tubulin binding (GO:0043014),-0.22321699330970285,-0.6722584354477352,0.9530201342281879,0.9915689930142187,1.0,9/31,21.46%,TTLL7;EML4;SNCA;TRPV4;PACRG;DLEC1;EFHC2;ARL4C;CDK5R1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.26332020049148663,0.66990704559607,0.8856749311294766,0.9665479058796275,1.0,21/40,35.60%,NNMT;PRMT8;PCMT1;DNMT3A;CARNMT1;GNMT;TARBP1;LRTOMT;DPH5;TPMT;ASMT;HNMT;THUMPD2;RRP8;METTL2B;METTL2A;MEPCE;PCMTD2;PCMTD1;METTL4;ARMT1
prerank,methyltransferase activity (GO:0008168),0.25889158689686054,0.669490611084295,0.8981723237597912,0.9648650849947937,1.0,24/46,35.77%,EHMT1;NNMT;PRMT8;CARNMT1;LRTOMT;PRMT5;NDUFAF7;FTSJ3;EEF1AKMT1;ASMT;TRMT11;MRM2;EEF1AKMT4;NSUN4;FTSJ1;RRP8;COQ5;PRMT3;MEPCE;METTL4;NSUN3;COQ3;ARMT1;AMT
prerank,thioesterase binding (GO:0031996),-0.2938710626082403,-0.6688234988134731,0.8710407239819005,0.9894646782378581,1.0,2/11,8.57%,ADRA2A;RAC1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.24270416316611856,0.6651501970015998,0.9251207729468599,0.967235706284685,1.0,11/85,14.13%,MGLL;PNPLA3;PLA2G4F;PON3;PLA2G15;ABHD6;DAGLB;PAFAH1B2;LYPLA2;LCAT;LYPLAL1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.31633450394632723,0.663624486662761,0.8466453674121406,0.9665646085215689,1.0,7/14,31.97%,AK4;AK9;AK1;NME6;AK5;CMPK1;DTYMK
prerank,NAD+ binding (GO:0070403),-0.28292178730118206,-0.6618941498555262,0.8811881188118812,0.9903164238864305,1.0,4/12,22.96%,UXS1;HADH;SIRT5;GLUD1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2630738016634423,-0.6615559224841144,0.8973105134474327,0.9854284955122496,1.0,6/15,25.33%,P2RY14;P2RY1;P2RX7;GPR34;PTAFR;P2RX3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3333653348991804,0.6608503220074159,0.8393782383419689,0.9670772485223349,1.0,3/12,13.87%,PIK3C2B;ATM;PIK3R3
prerank,NADPH binding (GO:0070402),0.3223271041915249,0.659664413059226,0.8363636363636363,0.9659951425606713,1.0,4/13,15.36%,DECR1;LBR;HMGCR;CBR3
prerank,retinoic acid receptor binding (GO:0042974),0.3006794435282633,0.6582130915990688,0.8718354430379747,0.9651966643536928,1.0,9/17,25.76%,NR4A2;RARG;NSD1;NRIP1;PPARG;NCOA6;SNW1;ASXL1;PRMT2
prerank,disordered domain specific binding (GO:0097718),0.2869176131556243,0.6578159759323452,0.8638426626323752,0.9633889822188411,1.0,4/23,16.22%,FN1;SMAD2;RB1;DFFB
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3062353830971414,0.6538234293287918,0.8421926910299004,0.9651736654957074,1.0,3/14,18.47%,MTMR12;SYNJ1;MTMR11
prerank,heme binding (GO:0020037),0.24389766099907462,0.6536198783166268,0.9301143583227446,0.9632126351122976,1.0,5/65,6.81%,CYP1B1;PTGIS;CYP2S1;HMOX2;PTGES2
prerank,Tat protein binding (GO:0030957),0.3267463214319439,0.6467733178272905,0.8516579406631762,0.9675956677865841,1.0,2/10,12.47%,MDFIC;SMARCA4
prerank,CCR chemokine receptor binding (GO:0048020),0.27005757050618445,0.6320558887759172,0.918918918918919,0.9784135028142618,1.0,4/28,13.07%,DEFB130A;CCL3;CCL1;CCL7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3061372763352774,0.6311180488312218,0.8834459459459459,0.9769975818757913,1.0,3/13,16.09%,SLC7A2;SLC38A7;SLC38A3
prerank,MAP kinase kinase activity (GO:0004708),-0.2535464141089053,-0.6308730621655774,0.8921568627450981,1.0,1.0,2/15,8.89%,MAP2K6;PAK3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.25228905363565685,-0.6305983198237566,0.9042553191489362,0.9991124504029106,1.0,6/16,23.70%,RPS3;CD38;MACROD1;SARM1;NEIL2;BST1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.26078739886747604,0.6278882701986642,0.9158878504672897,0.9775499597333267,1.0,3/29,8.41%,CIT;SPRED2;CDKN1B
prerank,lysophospholipase activity (GO:0004622),0.2816274253772721,0.6276225367186786,0.9,0.9755786650697011,1.0,5/20,20.14%,MGLL;LYPLA2;LYPLAL1;GDPD3;PLA2G4A
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3191891128799058,0.6267638258677937,0.8709122203098106,0.9741374347685088,1.0,2/10,9.61%,IDE;USP15
prerank,syntaxin binding (GO:0019905),0.23438518200995986,0.6258805058056943,0.9521410579345088,0.9727320980058836,1.0,8/61,11.14%,UNC13B;ABL1;PTPN2;VPS54;SYT8;NSF;STX8;SNAP23
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.21867431382712316,-0.6258446640640921,0.95,0.9973969839064357,1.0,7/26,22.64%,PPP1R1A;PPP1R14A;LMTK2;SET;BOD1;PABIR1;ENSA
prerank,RNA stem-loop binding (GO:0035613),0.29366141263679213,0.6142861748042,0.8839869281045751,0.9799572614666127,1.0,5/12,24.33%,ZC3H12A;DHX9;FMR1;EPRS1;RC3H2
prerank,chemokine receptor activity (GO:0004950),-0.21415218239619965,-0.6062975860206956,0.9646017699115044,1.0,1.0,1/24,1.78%,CCR9
prerank,semaphorin receptor activity (GO:0017154),0.2945345575910372,0.5985970766656801,0.9060283687943262,0.9889531542101434,1.0,3/11,18.59%,NRP1;PLXNA2;PLXNB1
prerank,channel activity (GO:0015267),0.2360684132623122,0.5918922511916529,0.9498607242339833,0.9913360233131585,1.0,4/41,11.15%,TMEM120A;AQP6;MCUB;CHRNG
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.20340352866420675,-0.5879554388409634,0.9711538461538461,1.0,1.0,13/26,32.61%,CSGALNACT1;CHSY3;CHSY1;B3GNT3;GBGT1;B3GALT2;CHPF;B4GALNT1;B3GALT1;B3GALT4;B4GALNT4;EXTL2;B3GALT5
prerank,glutathione transferase activity (GO:0004364),-0.2130045022283598,-0.5810681173823559,0.9722222222222222,1.0,1.0,12/23,34.52%,HPGDS;GSTA4;MGST1;GSTK1;GSTM1;ALOX5AP;GSTA3;MGST3;GSTM2;GSTZ1;LTC4S;GSTP1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.26492807987266226,0.5770400503415786,0.9418604651162791,0.9982794023491005,1.0,5/18,17.21%,SERPINB9;BIRC7;PRDX5;DPEP1;BIRC3
prerank,neuropeptide receptor activity (GO:0008188),-0.20053998225841224,-0.5742331148166366,0.9939577039274925,1.0,1.0,4/29,14.54%,SORCS2;SORCS3;GPR37;SORCS1
prerank,DNA polymerase binding (GO:0070182),0.2613489725996657,0.5661388002583907,0.9507154213036566,1.0,1.0,4/18,17.91%,SMG6;SMARCA4;POLG2;RAD51
prerank,acetylcholine receptor activity (GO:0015464),0.25405871654451495,0.5640701021651814,0.9549689440993789,1.0,1.0,4/22,16.16%,CHRM5;CHRNG;CHRNE;CHRNB1
prerank,nucleosomal DNA binding (GO:0031492),-0.2068927085764301,-0.5610246442318828,0.9703504043126685,1.0,1.0,2/21,9.14%,ACTB;MBD2
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2318358913866306,0.5602062953587933,0.96105702364395,1.0,1.0,8/34,18.44%,FAM20A;IQGAP1;MLST8;CAB39;STRADA;MAP2K2;CAB39L;CCNT1
prerank,ribonuclease P activity (GO:0004526),-0.23333356224631685,-0.5592105707454833,0.9534313725490197,1.0,1.0,7/11,41.64%,POP5;POP7;RPP21;PRORP;RPP25;RPP40;RPP14
prerank,neuropeptide hormone activity (GO:0005184),-0.20376884422110556,-0.5579959756755911,0.9602272727272727,0.9975776988781123,1.0,22/22,79.66%,PENK;NPY;PNOC;PPY;GAL;CALCB;UCN;NPPA;GHRH;NMB;NPFF;CCK;QRFP;CORT;OXT;ADCYAP1;CRH;AGRP;SPX;VIP;GRP;HCRT
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.24056508884380856,-0.5561165958084552,0.9537712895377128,0.9933918058339488,1.0,4/10,24.17%,STAMBPL1;ATXN3;TNFAIP3;CYLD
prerank,chemokine activity (GO:0008009),0.22741566960516885,0.5423742389784326,0.9673590504451038,1.0,1.0,4/31,13.07%,CXCL2;CCL3;CCL1;CCL7
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.26948012880306904,0.5401739893341382,0.9368600682593856,1.0,1.0,5/11,31.75%,BAG3;SIL1;GRPEL2;BAG2;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.26948012880306904,0.5401739893341382,0.9368600682593856,1.0,1.0,5/11,31.75%,BAG3;SIL1;GRPEL2;BAG2;BAG5
prerank,microtubule minus-end binding (GO:0051011),0.2622183210496811,0.5378528294958876,0.9341216216216216,1.0,1.0,4/13,22.12%,TUBGCP6;TUBGCP5;TUBGCP4;CAMSAP3
prerank,histone methyltransferase binding (GO:1990226),0.26942608967178283,0.5366515991764779,0.9451327433628318,1.0,1.0,2/11,12.08%,LCOR;NOP56
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.21229509294683568,-0.5286663446480437,0.96875,0.997834479002936,1.0,8/14,41.64%,POP5;POP7;RPP21;PRORP;TSEN34;RPP25;RPP40;RPP14
prerank,neuropeptide receptor binding (GO:0071855),0.25312227867453063,0.5211951697660219,0.9509803921568627,1.0,1.0,1/14,8.69%,SHANK1
prerank,palmitoyltransferase activity (GO:0016409),0.21954503664353023,0.5155146948039743,0.9720176730486009,1.0,1.0,13/28,30.16%,ZDHHC11;HHAT;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC24;ZDHHC5;GLUL;ZDHHC7;ZDHHC3
prerank,kinesin binding (GO:0019894),0.21372937334308947,0.5150797103048775,0.9746268656716418,1.0,1.0,9/27,27.32%,KIF1B;ARHGEF10;PLEKHM2;NEK6;TOR1B;MAPK8IP3;SPAG9;CROCC;IFT88
prerank,O-methyltransferase activity (GO:0008171),-0.22412883399088487,-0.511213718338998,0.9783132530120482,0.9976898049638236,1.0,1/10,7.88%,COMT
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2591550200241177,0.5057475222296964,0.959731543624161,1.0,1.0,3/10,21.66%,IDE;PML;ANKRD13D
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2548722112908542,0.5034315466845607,0.9473684210526315,1.0,1.0,4/10,28.54%,NAA15;NAA50;NAA80;NAA60
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.21817996097422582,-0.498898733446411,0.9650537634408602,0.9957956831762546,1.0,2/12,14.89%,TENT5A;PAPOLB
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.22734703799657346,0.49076356418318784,0.9697986577181208,1.0,1.0,3/16,18.47%,MTMR12;SYNJ1;MTMR11
prerank,chemokine receptor binding (GO:0042379),0.19966328967152078,0.48585529395719507,0.9899569583931134,1.0,1.0,4/35,13.07%,CXCL2;CCL3;CCL1;CCL7
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2292017993855209,0.46606286619245924,0.9828178694158075,1.0,1.0,6/12,31.54%,PAN3;CNOT7;PNLDC1;PARN;CNOT8;CNOT1
prerank,telomerase RNA binding (GO:0070034),0.2045282602533784,0.46271142535126797,0.9938080495356038,1.0,1.0,7/22,31.17%,SMG6;DHX36;NAF1;PARN;PINX1;GAR1;XRN1
prerank,carbohydrate kinase activity (GO:0019200),0.22930867949830883,0.46093360860220545,0.9759229534510433,1.0,1.0,3/11,25.14%,GALK2;GNE;POMK
prerank,RNA methyltransferase activity (GO:0008173),0.2079382026000129,0.45500329199903966,0.9936,1.0,1.0,19/19,79.23%,TRMT13;TRDMT1;FTSJ3;MRM2;TGS1;FTSJ1;TRMT12;MEPCE;METTL4;BCDIN3D;TRMT5;HENMT1;FBLL1;METTL8;FBL;LCMT2;TRMT9B;TYW3;METTL3
prerank,antiporter activity (GO:0015297),0.20512498429845477,0.45433682890519866,0.9889415481832543,0.9996439901080961,1.0,20/20,79.51%,ATP1A3;SLC25A14;SLC35D2;SLC25A16;CLCN4;SLC35E3;SLC35E2B;SLC35E2A;SLC35A1;SLC25A30;SLC35D3;TMEM241;SLC35C2;SLC25A10;SLC35C1;CLCN3;SLC35D1;SLC35E4;SLC25A11;SLC35E1
prerank,U6 snRNA binding (GO:0017070),0.2211453441413132,0.45270190808516797,0.9820261437908496,0.9978282392409851,1.0,3/14,24.24%,LSM2;LSM8;LSM4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.18918141987984355,0.41072119277239416,0.9902597402597403,1.0,1.0,6/16,35.36%,CDO1;TDO2;IDO2;HGD;ALOX5;PIR
prerank,neuropeptide binding (GO:0042923),-0.15347902537050992,-0.4024642502274387,0.9974424552429667,1.0,1.0,18/18,84.68%,GPR37;GPR149;NMUR1;OPRD1;MC4R;MCHR1;SSTR4;SSTR1;OPRK1;OPRM1;MRGPRX2;SSTR5;NPBWR1;NMUR2;SORL1;SSTR2;OPRL1;SSTR3
prerank,ribonuclease P RNA binding (GO:0033204),0.19997489329651022,0.39803255500139034,0.993103448275862,1.0,1.0,10/10,80.02%,RPP38;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP21;POP7;POP5
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.198167095599774,0.39243460367455507,0.9910071942446043,0.9989876513077589,1.0,11/11,80.20%,CHRNB1;CHRNA4;CHRNB2;CHRNA3;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA5;CHRNA9;CHRNA7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.1866596008441013,0.3846708029837933,0.9966216216216216,0.9974381144522368,1.0,4/12,28.87%,AIFM2;NQO1;CRYZL1;DHRS4
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.1439603214465093,-0.35072034803505514,1.0,0.9998023315887599,1.0,14/14,85.62%,CIAO3;RSAD2;ACO1;ISCA2;NDUFS1;EXO5;SDHB;ISCU;ACO2;NUBPL;RSAD1;IREB2;ETFDH;NFU1
